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ABSTRACT 
 
The aim of this thesis was to prepare three-dimensional scaffolds that can be potentially used 
for the reconstruction and regeneration of damaged bone tissues. Two techniques were used 
to create the porous ceramic scaffolds – polymer replica technique and polymerization in situ. 
A variety of bioceramic materials were studied, mainly alumina, zirconia and calcium 
phosphates. The effect of processing parameters, such as composition of suspensions, as well 
as the effect of heat treatment on structure and final properties of the prepared scaffolds 
were evaluated. Morphology of the sintered scaffolds was characterised by scanning electron 
microscopy; in particular pore size, pores interconnection, total porosity and density were 
described. Phase composition, compressive strength and biological properties such as 
bioactivity and cytotoxicity were also discussed. 
The dissertation is divided into several sections. The literature review briefly summarizes 
the structure and properties of bones, the requirements for scaffolds, advantages and 
disadvantages of currently used materials and methods of ceramic foam preparation. The first 
part of experiments dealt with scaffolds prepared by polymer replica technique. All fabricated 
foams had interconnected pores with size in the range of 300 to 2000 μm, total porosity was 
50–99%. The compressive strength of calcium phosphate foams prepared by replica technique 
reached about 0.3 MPa (at 80 % porosity). Reinforcement of the scaffolds was reached by 
using bio-inert cores or by incorporation of silica into the composite structure. The strength 
of calcium phosphate/silica scaffold increased above 20 MPa. The last section of experimental 
part discusses in situ blown calcium phosphate scaffolds, created by using the formation 
process of polyurethane foam with diisocyanate and polyol components. The sintered 
scaffolds had mainly interconnected macroporous structure with pore size ranging 80 to 
550 μm. The total porosity was about 76 to 99 %. The advantage of this method compared 
to the polymer replica technique was that the struts were completely filled. 
None of the studied materials was cytotoxic and moreover all studied foams exhibited 
bioactive behaviour. The most promising adept for application in bone tissue engineering 
seems to be composite material containing calcium phosphates reinforced by silica. 
 
ABSTRAKT 
 
Cílem disertační práce bylo připravit trojrozměrné biokeramické podpůrné systémy 
(„skafoldy“), které by v budoucnu mohly pomoci při rekonstrukci a regeneraci poškozených 
kostních tkání. Porézní keramické pěny byly připraveny dvěma způsoby – replikační technikou 
a polymerizací in situ. Co se složení týče, byly studovány keramické materiály zejména na bázi 
oxidu hlinitého, zirkoničitého a kalcium fosfátů. Byl studován jednak vliv procesních parametrů 
jako je složení suspenzí a jejich viskozit, dále pak vliv tepelného zpracování na strukturu a 
výsledné vlastnosti připravených materiálů. U slinutých pěn byla pomocí rastrovací 
elektronové mikroskopie hodnocena zejména morfologie – velikost pórů, jejich propojenost 
a celková porozita, charakterizace mikrostruktury nebyla opomenuta. Dále bylo stanoveno 
fázové složení a pevnost v tlaku. Z biologických vlastností byla testována a diskutována 
bioaktivita a cytotoxicita materiálů. 
Disertační práce je členěna do několika částí. V literární rešerši je popsána stavba a vlastnosti 
kosti, požadavky kladené na kostní náhrady, výhody a nevýhody současně používaných 
materiálů a způsoby přípravy keramických pěn. Následuje experimentální část, kde byly 
nejprve studovány pěny připravené replikační technikou. Všechny takto vyrobené pěny měly 
propojené póry o velikostech 300 až 2000 μm, celková porozita se pohybovala v rozmezí 50 – 
99 %. Pevnost pěn na bázi kalcium fosfátů – 0,3 MPa (při celkové porozitě 80%) byla 
nedostatečná pro kostní náhrady, kde je požadována pevnost větší než 2 MPa. Kalcium 
fosfátové keramiky byly tedy zpevněny buďto inertním jádrem na bázi oxidu hlinitého nebo 
ATZ (oxidem zirkoničitým zhouževnatělým oxidem hlinitým). Dále byl přípraven částicový 
kompozit, ve kterým byl hydroxyapatit pojený oxidem křemičitým. Pevnost pěn se podařilo 
zvýšit až na více než 20 MPa. V poslední kapitole experimentální části byly studovány 
keramické pěny pěněné in situ, kde byly póry vytvářeny oxidem uhličitým unikajícím během 
reakce mezi diisokyanátem a polyalkoholem. Po vypálení polymerního pojiva měly pěny 
propojené póry o průměrné velikosti 80 až 550 μm. Celková porozita se pohybovala v rozmezí 
76 – 99%. Výhodou oproti replikační technice byly plné trámečky bez velké středové dutiny 
vznikající vypálením polymerní předlohy. 
Žádný ze studovaných materiálů nebyl pro buňky toxický, navíc všechny studované pěny 
vykazovaly bioaktivní chování. Z hlediska kostního tkáňového inženýrství se jako nejslibnější 
jeví kompozitní materiál zpevněný oxidem křemičitým. 
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 1 INTRODUCTION 
The life expectancy increased by about 30 years during the 20th century [1]. This rapid 
rise has brought new health issues. Nowadays, we face problems relating to numerous bone 
disorders, thus, the need for load-bearing bone graft substitutes is rising hand in hand with 
the amount of active elderly people.  
Bone is one of the tissues which are able to completely regenerate by themselves, but 
only in case that the damaged part is small enough. If not, it is necessary to help bone to 
restore its damaged part by using bone grafts [2]. Currently, a few million people need a bone 
graft each year [3] and it is expected that the demand will grow steadily. 
The best grafts have mechanical and biological properties as similar as possible to those 
of normal bone. The most suitable properties naturally have autografts, i.e. parts of bone 
harvested from the patient’s own body, usually from an iliac crest. Autografts eliminate a risk 
of immunogenic rejection; on the other hand, drawbacks are a lack of available material and 
the necessity of two surgical procedures, leading to more pain and the higher risk of infection. 
Moreover, up to 30% occurrence of complications was reported [2]. A possible alternative 
to autografts is using of allografts. The allograft is a bone taken from another patient, usually 
obtained from a bone bank. Nearly one third of all bone grafts used in North America are 
allografts [4]. Allografts have osteoconductive properties; however, they carry the risk 
of infection, rejection and disease transmission. These disadvantages are minimalized through 
a multi-step sterilization process, which leaves most allograft tissues void of its osteoinductive 
potential and unfortunately also reduces the mechanical properties of the replacement. 
Because of the above mentioned weaknesses the need for development of a new type of graft 
is strong and synthetic scaffold seems to be a promising way. 
This thesis aims to contribute to the search for a suitable bone substitute. Several types 
of porous ceramic materials were studied. The first part of the experiments were focused on 
the scaffolds prepared by polymer replica technique. The objective was to prepare scaffolds 
with higher strength than the strength of porous hydroxyapatite. Strengthening was achieved 
by using bio-inert cores and by incorporation of silica into the structure. The second part was 
oriented toward in situ blown calcium phosphate scaffolds which strength was higher 
compared to polymer replica technique due to dense struts. 
 
 
 
 
2 
 
2 LITERATURE REVIEW 
2.1 Bone structure 
Bone can be referred to either as an organ or a tissue. Generally, bones are organs made 
up of bone tissue, bone marrow, blood vessels, epithelium, and nerves, while the term bone 
tissue speciﬁcally refers to the mineral matrix that forms the rigid sections of the organ [5-7]. 
Bone is one of the hardest tissues in the body — this connective tissue is composed 
of extracellular matrix and cells (osteocytes, osteoblasts, osteoclasts). Bone serves several 
functions in the organism: (1) a structural support for the mechanical action of soft tissues, (2) 
a protection of soft organs and tissues, (3) a source of cells that produce red and white blood 
cells, and (4) a mineral reservoir [8]. 
Bones exhibit a complex hierarchical structure (see Fig. 1) which provides unique 
mechanical, chemical and biological functions. Seven structural levels can be distinguished 
in bone’s structure [9-12]: 
1) The sub-nano structure (less than a few hundred nanometres): molecular structure 
of mineral, collagen and non-collagenous organic proteins. 
2) The nanostructure (0.2–1 µm):  mineralized collagen fibrils. 
3) The nanostructure (1–10 µm): fibril arrays. 
4) The sub-microstructure (3–50 µm): fibre patterns, single lamellae. 
5) The microstructure (50–500 µm): Haversian system, osteons, trabeculae. 
6) The mesostructure: cortical and cancellous bone. 
7) The macrostructure: the whole shape of bone. 
 
 
Fig. 1 Hierarchical structure of bone [10]. 
Cancellous bone 
Cortical bone 
Osteon 
Lamella 
Collagen 
fibre 
Collagen 
fibril 
Collagen 
molecule 
Bone 
crystals Haversian 
canal 
10-500 µm 
0.5 µm 
1 nm 
3-7 µm 
Microstructure   Nanostructure 
Macrostructure   Sub-microstructure   Sub-nanostructure 
3 
 
2.1.1 The major components 
Three main components can be distinguished at the sub-nanostructure level: (1) small 
plate-shaped crystals of apatite (see Fig. 2a), (2) macromolecules, of which type I collagen 
is the major constituent, and (3) water [5]. 
         
Fig. 2 Major components of bone: (a) isolated apatite crystals [11]; (b) collagen fibril [13]. 
Mineral phase 
The mineral phase represents about two thirds of the weight of a dry bone, or half of 
its volume [5]. The chemical composition of bone crystals resembles the chemical 
compositions of stoichiometric hydroxyapatite (HA). The difference is that the biological 
bone crystals contain significant and varying amounts of carbonate and hydrogen-
phosphate ions and less hydroxyl groups than is in the stoichiometric hydroxyapatites [10, 
14]. Bone mineral can be thus considered as an impure form of HA, with a variable 
Ca/P molar ratio in the range 1.6–1.7 (the theoretical value for stoichiometric 
hydroxyapatite is 1.67) [15]. 
The general formula of apatites is Ca10(PO4)6X2 where X denotes F-, OH- 
(hydroxyapatite) or Cl-. Indexes show that crystallographic unit cell consists of two 
formula units Ca5(PO4)3X. As is evident from Fig. 3, hydroxyapatite crystallizes in the 
hexagonal system. 
 
Fig. 3 Structure of hydroxyapatite [16]. 
The apatite lattice is prone to substitutions, vacancies, and solid solutions, such 
as CO32-, F-, Cl-, Na+, K+, Fe2+, Zn2+, Sr2+, Mg2+ and citrate [17]. A bone apatite contains about 
7–7.5 wt. % of carbonate which dominantly substitutes PO43- ion [5, 17, 18]. Wopenka 
[17] documented that carbonate substitution in hydroxyapatite causes changes in several 
physical properties; a drop of the thermal stability and reduced crystallite volume was 
observed; the a–axial length decreases whereas the c–axial length increases compared to 
non-substituted ceramic apatites. Another consequence of substitution is that the 
carbonate-containing apatite has higher solubility compared to the carbonate-free 
a) b) 
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apatite because the Ca–CO32- bond is weaker than the Ca–PO43- bond. Furthermore, 
simultaneous presence of other substituting ions influences the morphology 
of biologically produced apatite which forms nanocrystalline blocks or platelets. Contrary, 
synthetically and geologically formed apatite usually occurs in the shape of prisms and 
needles [17].  
The documented dimensions of apatite crystals in bone are following: the length of 
30–50 nm, width of 15–30 nm and thickness of 2–10 nm [11, 19]. AFM studies revealed 
that the bone crystals may be longer than those observed by TEM, with widths and 
lengths ranging from 30 to 200 nm [20].  
Collagen framework 
The organic matrix of the bone consists of collagen (85–90 %) and a series of non-
collagenous proteins and lipids. The collagen (type I) molecules secreted by osteoblasts 
are self-assembled into fibrils. Each fibril consists of three (two α1 and one α2) polypeptide 
chains about 1000 amino acids long which are wound together in a triple helix. A triple-
helical molecule is cylindrically shaped with an average diameter of around 1.5 nm, 
and lengths of 300 nm (see Fig. 4). The fibrils are all parallel with their ends separated 
by gaps of about 35 nm; furthermore, the neighbouring triple-helical molecules are offset 
or staggered by 67 nm [11, 21-23]. 
 
Fig. 4 Collagen: from top to bottom—collagen α–helix composed of amino acids, single triple-
helical molecule, 2-dimensional section through part of a fibril showing the staggered array, 
a collagen fibril [13]. 
2.1.2 Types of osseous tissue 
At the mesostructure level bone exists in two forms: cortical (also known as compact 
or dense) and cancellous (known as spongy, or trabecular) bone. Long bones consist of a dense 
Type I Collagen Fibrils 
Collagen α Helix 
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cortical shell with a porous, cancellous interior (see Fig. 5); whilst flat bones such as 
the calvaria have a sandwich structure; two thin layers of compact bone enclosing between 
them a variable quantity of cancellous bone [24].  
 
Fig. 5 Fracture surface of human femur [11]. 
Cortical and cancellous bones can be distinguished by the porosity or more precisely 
by means of histological evaluation. The porosity of the compact bone is about 5–30 %, the 
porosity of the cancellous bone varied between 30–90 % [25]. In general, cancellous bones 
are much more metabolically active, thus they are remodelled more often than cortical bones. 
The cancellous bone is composed of a network of trabeculae that make the overall organ 
lighter and allows enough free space for blood vessels and marrow. Even though cancellous 
bone accounts only 20 % of total bone mass, it covers nearly ten times the surface area 
of compact bone [4, 9, 10, 21, 23]. 
2.1.3 Mechanical properties of bone 
Estimation of mechanical properties of bone is a quite challenging issue. Mechanical 
properties vary not only from place to place, patient to patient; they are influenced by age, 
gender and health of donor, by the freshness of samples, mineral and water content, and so on 
[26]. In general, bone is an anisotropic material with different properties in longitudinal and 
transverse directions. Mechanical properties of bone depend especially on the degree of 
mineralization and porosity of the matrix. Generally,  the bone matrix is more mineralized and 
thus stiffer and more brittle when the human gets older [27]. 
Modulus 
Bone can be simply considered as a fibre composite; hereby the Young’s modulus can 
be calculated using the rule of mixtures (eq. 1) and the inverse rule of mixtures (eq. 2): 
𝐸𝑎𝑥 = 𝑓 ∙ 𝐸𝑓 + (1 − 𝑓) ∙ 𝐸𝑚,                        (1) 
 𝐸𝑡𝑟𝑎𝑛𝑠 = [
𝑓
𝐸𝑓
+
(1−𝑓)
𝐸𝑚
]
−1
            (2)  
where ax means axial and trans transverse, Ef, Em are Young’s Modulus of fibres and 
matrix, f is volume fraction of fibres [26]. These equations show that bone is stiffer 
in the axial direction, parallel to the osteons. The measured modulus in axial direction 
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is considerably lower, because collagen fibres are not oriented parallel to the axis and 
bone mineral do not form a continuous matrix. 
The Young’s modulus is mainly a function of bone density [27]. In theoretical 
calculations, pores can be considered as the third phase. As is obvious from the Table 1, 
the Young’s modulus of cortical bone is one order of magnitude higher than the 
cancellous bone one. The measured values decrease with a temperature increase; and 
the modulus is highly dependent on the strain rate (the modulus is increasing with 
an increasing strain rate) [26].  
The elongation of bone is only 0.2–4.5% in case of cortical bone and 1.5–7 % in case 
of trabecular bone [26, 28]. 
 
Table 1 Young’s modulus of bone and its components (GPa) [26-29]. 
Material Young’s  modulus (GPa) Density (g∙cm-3) 
Collagen (dry) 6 1.33 
Hydroxyapatite 80 3.16 
Cortical bone, longitudinal direction 11–21 (up to 55) 2.5 
Cortical bone, transverse direction 5–13 2.5 
Cancellous bone 0.01–0.5 0.2-2 
Strength 
The human skeleton is a highly organized system, accordingly to functions. Particular 
bones in the body need to withstand different mechanical forces, so there is a huge 
variation in measured values of all tensile, compressive, shear, torsional, and bending 
strength of bones (see Tab. 2) [27]. Bone is the strongest in compression, the weakest 
in shear, and, intermediate in tension. Bones must be loaded constantly, in order 
to perform their functions and to be able to remodel, and thus remain healthy. If they are 
under-stressed for prolonged periods of time, they become thinner and less strong 
(in case of bed ridden patients or astronauts). Oppositely, higher levels of stress lead 
to increase of bone mass. In general strength decreases when a person gets older [26]. 
Table 2 Strength of bone  [26, 27]. 
Fracture toughness 
The fracture toughness of living bone is excellent, the fracture energy (Gc = 1.5 kJ∙m-2) 
is nearly comparable to steel [27]. As well as other mechanical properties, the measured 
value is depended on the measuring direction. Higher values of fracture toughness have 
been obtained in the transverse direction because of the unique hierarchical structure, 
where the canal inside the osteon can stop vertical external crack by lowering the critical 
Strength Longitudinal Transverse 
Tensile strength (MPa) 60–70 (femur: 89–118) approx. 50 
Compressive strength (MPa) 70–280 cortical bone approx. 50 
Compressive strength (MPa) 0.2–20 cancellous bone  
Bending strength (MPa) approx. 76, resp. 28–281 (femur) 
Torsional strength (MPa) 65–71 (femur) 
Flaking strength (MPa) 116 (femur) 40–92 (femur) 
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stress-intensity constant at the crack tip. The lower fracture toughness in longitudinal 
direction can be moreover explained by the presence of the cement lines, which are 
the weakest parts of the structure [30]. The fracture toughness of cortical bone is typically 
in the range 2–12 MPa∙m1/2 [29]. 
Bones naturally exhibit several toughening mechanisms, which are shown in Fig. 6. 
At the lowest level, plasticity is achieved through the mechanisms of molecular uncoiling 
and intermolecular sliding of molecules of collagen. On the scale of the fibril arrays, 
microcracking and fibrillar sliding act as plasticity mechanisms. At micrometre 
dimensions, the breaking of sacrificial bonds at the interfaces of fibril arrays leads 
to increased energy dissipation, together with crack bridging by collagen fibrils. In the 
range of tens to hundreds of micrometres, the fracture energy is reduced by the crack 
deflection [12, 30]. 
 
Fig. 6 The prevailing toughening mechanisms from the nano to macro structure [12]. 
2.1.4 Principles of bone remodelling and healing 
Bone remodelling 
Bone is a dynamic living tissue which constantly undergoes remodelling. 
The remodelling cycle (see Fig. 7) lasts around 6 months. About 10 % (25 % of trabecular 
bone while only 3 % of cortical bone) of the skeleton is renewed by remodelling each year 
[31].  
 
Fig. 7 Scheme of bone remodelling process [32]. 
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The old bone is removed by osteoclasts whereas new tissue is formed by osteoblasts. 
Osteoclasts dissolve the mineral phase via locally decreasing pH, resulted a small cavity 
created on the surface. Subsequently, bone forming cells called osteoblasts begin to fill in 
the cavity with the osteoid which mineralized in new bone tissue [32]. Osteoblasts activity 
decreases with age leading to imbalance of resorption and formation of new bone. 
Bone healing 
The body begins the healing process immediately after the breaking a bone. A clot 
forms at the site of the fracture within 48 to 72 hours after the injury, resulting 
in an inadequate blood supply that leads to the local bone necrosis. The dead cells 
provoke migration of fibroblasts and osteoblasts to the fracture site (within 3 days 
to 2 weeks). A fibrocartilaginous soft callus is formed around the fracture side (within 
2 to 6 weeks). The callus is then transformed into hard bone callus (within 3 weeks to 
6 months); excessive material of the bone is resorbed. Fig. 8 summarizes the stages of 
bone healing. Healing takes from about 6 weeks (young, healthy adult) to 3–6 months 
(older person with reduced bone mass) [24]. 
 
Fig. 8 Schematic illustration of the bone healing process [24]. 
2.2 Artificial materials for bone tissue engineering 
Tissue engineering is a multidisciplinary field involving material sciences, life sciences, 
medicine and clinical practice to solve the critical medical problems, such as tissue loss 
and organ failure. Before a more detailed description of tissue engineering, it is useful 
to define basic terms that are often confusing: osteoconduction, osteoinduction, 
osteoproduction, osteogenesis and osseointegration. 
Osteoconduction is a process whereby microscopic and macroscopic scaffolding 
is provided for inward migration of cellular elements involved in bone formation. 
An osteoconductive material permits bone growth on its surface or down into pores 
or channels and thus help the reparative growth of the natural bone [33]. 
Osteoinduction is a process which encouraging undifferentiated cells to differentiate 
into active osteoblasts under the influence of a diffusible Bone Morphogenetic Protein, the 
type of growth factor [33]. 
The term osseointegration means the formation of a direct interface (without 
intervening soft tissue) between an implant and bone. Nowadays, an implant is considered to 
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be osseointegrated when there is no progressive relative movement between the implant and 
the bone in direct contact [34].  
 Osteoproduction is the ability of directly producing bone via the existence of bone-
forming cells within the graft. It is a combination of osteoinductive, osteoconductive, and/or 
osteogenic properties of a grafting material [35, 36]. 
Osteogenesis means that new bone can be formed from the transplanted living cells 
[37].  
2.2.1 Requirements for bone scaffold 
Currently used implants usually lack three important characteristics of living tissues: 
(1) the ability to self-repair; (2) the ability to maintain a blood supply; and (3) the ability to 
modify their structure and properties in response to environmental factors such as mechanical 
load [38]. Nowadays, the goal of bone tissue engineering is not to permanently replace 
the damaged bone tissue by synthetic scaffold, but provide a support for its regeneration as 
long as necessary. The scaffold should help to stimulate bone growth and attract newly 
formed bone tissue, before being remodelled [38].  
Because a human body is a complex and sensitive system, the requirements for 
scaffold materials are manifold and extremely challenging. The ideal scaffold for bone tissue 
engineering should meet the following criteria [39]:  
The biocompatibility is an essential property; it means that the material must not elicit 
an inflammatory response nor demonstrate immunogenicity or cytotoxicity.  
The scaffolds are artificial, lattice-like structures capable of supporting a tissue 
formation.  This three dimensional structures are typically engineered with pores allowing 
cells to migrate throughout the material and support vascularization of the ingrown tissue. 
A blood supply in and around the implant would be created within a few weeks after 
implantation. 
 Pores should be interconnected with pore size minimally 100 µm in diameter (ideally 
about 150 - 500 µm) [40, 41]. Besides macropores, microporosity of the walls (< 100 µm) 
is desirable because it provides a larger surface area which is significant for protein adsorption, 
cellular adhesion and proliferation [41]. 
Besides that, scaffolds should be further able to create a stable interface with the host 
bone without fibrous connective tissue. Its surface texture should promote cell adhesion and 
adsorption of biological metabolites [42]. In addition, it should support cell differentiation and 
proliferation [38]. 
Over a few months’ time, the scaffold ought to resorb in the body, leaving behind the 
natural tissue. Resorption kinetics should be equal to the bone repair rate in order to facilitate 
load transfer to developing bone. The by-products must not be toxic and should be easily 
eliminated via the respiratory or urinary systems [43]. 
Above that, mechanical properties of the scaffold must be sufficient and the scaffold 
must not collapse during handling and in vivo during the normal physical activities. Mechanical 
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properties should be ideally similar to those of the host bone to avoid several problems such 
as stress shielding. Stress shielding occurs if the Young’s modulus of an implant is higher than 
that of bone. If it happens, the implant carries nearly all the load, the result bone becomes 
weaker, and the interface between the bone and the implant deteriorates [36]. The optimal 
Young's modulus of dense implant should be in range 15–20 GPa or 0.1–2 GPa in the case of 
cellular scaffolds. Compressive strength should be 100 to 200 MPa, or 2 to 20 MPa 
respectively. Last but not least, scaffolds should be easily manufactured in desired shapes 
which would match the defect in the bone. 
Hence, the intrinsic structure as well as the composition plays critical roles in the 
success of a scaffold.  
2.2.2 Types of biomaterials 
In general, scaffolds are made of organic or inorganic materials. Up to date, the most 
published papers in the field of biomaterials deal with polymers [41]. 
A material that would meet all requirements for an ideal bone graft has not been 
developed so far. Metals, for example, exhibit mechanical properties appropriate for load 
bearing applications but their biocompatibility is not satisfactory. Ceramic materials are on the 
other hand usually biocompatible, sometimes even bioactive; however, their innate 
brittleness limits their widespread. Polymeric porous scaffolds can be resorbable in vivo but 
they have insufficient stiffness and compressive strength… Similar as in bone, it is convenient 
to combine different groups of materials with the aim to increase the mechanical stability 
of the scaffold and improve the tissue interaction. In the last decade, there have been many 
efforts to develop scaffolds with a drug-delivery capacity. These scaffolds can locally release 
growth factors or antibiotics to enhance bone ingrowth to treated bone defects and thus 
support wound healing. Various types of materials were intensively studied.  
2.2.3 Metals 
The main advantage of metal implants is their superior mechanical properties, such 
as high tensile strength and fatigue resistance. Metals are so far the most often implanted 
material for load bearing applications. Disadvantages are the lack of tissue adherence and 
the risk of toxicity due to accumulation of released metal ions [41, 44]. Moreover, the higher 
Young’s modulus induces stress shielding.  
Commonly used metals are stainless steel or titanium alloys (such as Ti-6Al-4V). 
Titanium and its alloys are usually used for internal and external fixation and for hard tissue 
replacements of bones, joints and dental implants. The benefit of titanium is a spontaneous 
formation of protective titanium oxide on its surface. Porous metallic scaffolds are made 
of titanium, tantalum or magnesium [3, 44]. Magnesium alloys can degrade in vivo by MgOH 
which can temporarily enhance osteoblast activity [2]. Metallic grafts have few indications 
such as in spine surgery [45]. 
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2.2.4 Polymers 
Organic materials are the most studied group of biomaterials mainly because of their 
biocompatibility or sometimes even bioactivity or biodegradability [2]. Polymers can be both 
naturally derived and synthetic origin. Natural polymers used for scaffolds are collagen, fibrin, 
alginate, silk, hyaluronan, and chitosan [44]. Commonly used synthetic polymers are 
poly(lactic acid) (PLA), poly(glycolic acid) (PGA), their copolymer (PLGA), polyethylene glycol 
(PEG) and polycaprolactone (PCL), poly(propylene fumarate) (PPF) [46]. An advantage 
of synthetic polymers is a tuneable biodegradation and highly predictable properties [41]. 
Scaffolds with different porosities and surface characteristics can be processed by different 
techniques such as gas foaming, emulsion freeze drying, porogen leaching, thermally induced 
phase separation, supercritical fluid processing, nanofibre electrospinning process, and 3D 
printing [47, 48]. 
Polymers degrade in vivo primary by chemical reactions like hydrolysis and only slightly 
by enzymatic and cellular pathways. Degradation of certain polymers (such as PLA, PGA) 
is associated with an increasing acidity of local environment which can negatively influence 
tissue responses [46]. Some of the degradation products may even cause immunological 
reactions. Polymers exhibit several problems such as absence of direct bone bonding and 
integration. Young’s modulus (7 MPa for elastic polymers and 4 GPa for stiff polymers) is lower 
than that of bone [41]. Polymers usually do not reach sufficient mechanical stability and thus 
cannot be used for load bearing applications [2, 41, 45]. 
A more detailed description of purely organic materials is behind the scope of this 
thesis and can be found elsewhere [48-51]. 
2.2.5 Ceramics 
Oxide ceramics typically exhibit an excellent biocompatibility.  According to the level 
of interaction with tissues, Hench [36] divided materials into the following categories: 
(1) nearly inert, (2) porous, (3a) bioactive class A, (3b) bioactive class B, and (4) resorbable. 
The level of bioreactivity is illustrated in Fig. 9. 
 
Fig. 9 Classification of bioceramic implants according to the bioreactivity and time dependence 
of formation of bone bonding at an implant interface: (A) 45S5 Bioglass, (B) Mina13 Ceravital, 
(C) 55S4.3 Bioglass, (D) A/W glass-ceramics, (E) HA, (F) KGy213Ceravital, (G) AI2O3-Si3N4 [36]. 
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Bioinert ceramics 
In fact, no material implanted into living tissues is strictly inert. A tissue tends 
to encapsulate the implant by a non-adherent fibrous layer. The interface is neither 
chemically nor biologically bonded so micromotion can occur. Bioinert ceramics are often 
used for articulating surfaces because of their excellent tribological properties.  
 Alumina 
Alumina has found applications in tissue engineering since 1970s [52]. It is mainly 
used for load-bearing hip prosthesis or dental implants. More than 10 million alumina 
femoral heads were implanted by 2006. Alumina implants are usually made of very fine 
grained polycrystalline alumina; chemically, they are compounded of highly pure 
(99.5%) Al2O3 with a small amount of MgO which serves as a grain-grow inhibitor. 
Alumina exhibits excellent biocompatibility and wear resistance however flexural 
strength is only moderate and fracture toughness is quite low [52]. Mechanical 
properties are listed in Table 3 
 Zirconia 
Zirconia [53] is a material with undoubtedly best mechanical properties among other 
bioceramics. It has relatively high flexural strength, lower modulus than alumina, and 
due to stabilization of tetragonal phase excellent fracture toughness (see Table 3). 
Zirconia can be stabilized by e.g. Y, Mg, Ca, Ce oxides. Tetragonal phase is usually 
stabilized by 3 mol % of Y2O3. A disadvantage of Y-ZrO2 is aging which occurs in body 
fluids. The aging results in a slightly decrease of strength and fracture toughness [52]. 
Typical applications in biomedicine are similar to alumina.  
Table 3 Mechanical properties of bioinert ceramics [52, 53] 
Material Density 
(g∙cm-3) 
Compressive 
strength 
(MPa) 
Young 
modulus 
(GPa) 
Fracture 
toughness 
(MPa∙m1/2) 
Temp. 
coeff. 
(ppm/°C) 
Hardness 
(HV 0.1) 
Fr. surface 
energy 
(J∙m-2) 
Al2O3 3.85-3.99 3000-5000 380-410 3-6 6-9 2200 7.6-30 
PSZ 5.6-5.89 1850-2000 195-210 5-8 7-10 1200 160-350 
TZP 5.6-5.89 1850-2000 195-210 7-10 11 1200 160-350 
Bioactive ceramics 
Hench defined the concept of bioactivity in 1971 as follows: “A bioactive material 
is one that elicits a specific biological response at the interface of the material which 
results in the formation of a bond between the tissues and the material“ [54]. A common 
characteristic of bioactive ceramics and glasses is a time-dependent kinetic modification 
of the surface that occurs after implantation. The bonding interface with tissues 
is provided by a biologically active layer of hydroxy carbonate apatite (HCA) created 
on the surface. The HCA phase formed on bioactive implants is chemically and structurally 
close to the mineral phase in bone. The HCA is the only common characteristic of all 
the known bioactive implant materials. The in vivo formation of an apatite layer on the 
surface of bioactive ceramics can be reproduced in vitro by a protein-free and acellular 
simulated body fluid (SBF), which has an ion concentration similar to the human blood 
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plasma [36]. For more detailed information see Chapter 4.2.3. The rate of development 
of the bond is described by level of bioactivity IB, which is related to the time when more 
than 50% of the interface is bonded [36]. 
  Hench distinguished two types of bioactive materials: (A) class A, osteoproductive 
materials which can directly bond to both hard and soft tissue and (B) class B, 
osteoconductive materials which elicits only an extracellular response at its interface. 
Only a few bioglasses belong to class A [36]. 
 Calcium phosphates substituted by silica 
Silica-based materials have many applications in medicine and biotechnology, e.g. for 
bone-repairing devices [55-61], drug delivery systems [62] and cancer therapies [63-66]. 
Especially silica-based glasses became due to their bioactivity the most widely 
investigated materials for tissue regeneration during the last 40 years [55, 56]. Detailed 
information can be found in one of the very nice reviews written by father of bioglass, 
Larry Hench [67-69]. 
 Bioactive glass 
Bioactive glass was discovered by Hench in 1969. It exhibits an excellent 
biocompatibility as well as the bone bonding ability. Through interfacial and cell 
mediated reactions, bioactive glass develops a calcium deficient, carbonated phosphate 
surface layer that allows chemically bonding to host tissue. Bioactive glasses 
furthermore support enzyme activity, vascularization, osteoblast adhesion, growth, 
differentiation; and induce the differentiation of mesenchymal cells into osteoblasts 
[29]. 
Nearly all bioactive glasses are composed of SiO2, Na2O, CaO, and P2O5. Commonly 
used 45S5 Bioglass contains 45 wt% SiO2, 24.5 wt% Na2O, 24.5 wt% CaO and 6 wt% P2O5 
[58]. Bioglasses are by bioactivity level divided into several groups. According to Fig. 10, 
glasses in the centre (red region) have the highest level of bioactivity, i.e. they are class-
A bioactive. Glasses of compositions in region B are only osteoconductive. 
 
Fig. 10 Phase diagram of bioglasses, 6 wt% P2O5 [70]. 
Bioglasses are biologically active in case of containing vitreous phase. If they are 
in region E of Fig. 10 they are crystalized and thus bioinert. This limits their application 
as scaffold materials, because full crystallization happens prior to densification 
by viscous flow sintering. Extensive sintering is necessary to densify the struts of 
a scaffold to achieve the required mechanical properties. 
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Overall, mechanical properties are not good (see Table 4). Fracture toughness 
(approximately 1 MPa∙m1/2[71]) and mechanical strength are low, especially in porous 
form, hence, bioactive glasses cannot be used for load-bearing applications.  
 Glass-ceramics 
The glass-ceramics is a material which is obtained by using of an appropriate thermal 
treatment of glass that results in the nucleation and growth of specific crystal phases 
within the residual vitreous matrix. In general, mechanical properties are improved 
compared to the bioglass (see Table 4). The oldest type is Ceravital glass-ceramic which 
bioactivity is two times lower than that of bioglass of similar composition [72]. 
Apatite-wollastonite (A/W) glass-ceramic is composed of oxyfluorapatite, 
wollastonite (β-CaSiO3) and vitreous phase. Bending strength and fracture toughness 
of A/W glass-ceramics is improved because of the precipitation to wollastonite as well 
as apatite phases [29].  
Table 4 Mechanical properties of bioglass and glass-ceramics [73]. 
 
 Bioglass 45S5 Ceravital A/W 
Flexural strength (MPa) 42 100-150 220 
Compressive strength (MPa) 160-190 500 1060 
Young’s Modulus (GPa) 35 100-159 118 
 
 Hydroxyapatite  
Hydroxyapatite is a non-resorbable calcium phosphate. Due to chemical composition 
and crystallography similarity to bone mineral, hydroxyapatite exhibits an excellent 
biocompatibility, and therefore it is extensively studied for bone tissue substitutions. 
Despite not being osteoinductive, hydroxyapatite is osteoconductive and able to directly 
bond to bone. HA enhance the attachment, differentiation, and proliferation of relevant 
cells (such as osteoblasts and mesenchymal cells). Its application in bone tissue 
engineering is, however, limited due to low mechanical strength and very slow 
biodegradation. The dissolution rate of synthetic HA is depended on the crystallinity, 
porosity and composition (impurities) of the HA phase; type, concentration and pH 
of the solution, degree of the solution saturation, solid/solution ratio, etc. Crystalline HA 
exhibits the slowest degradation rate of all other calcium phosphates  
Mechanical properties are influenced by porosity, crystallinity, grain size, and 
composition as well. The stiffness, strength and toughness can be enhanced by using 
crystalline, low porous small-grain-sized HA. Compared to a cortical bone, compressive 
strength of synthetic HA is higher, however, fracture toughness is significantly lower due 
to missing collagen fibres [29]. Mechanical properties are summarized in Table 5. 
Table 5 Mechanical properties of calcium phosphates [74]. 
 K1c (MPam1/2) strength (MPa) Vickers hardness 
Hydroxyapatite [74] 0.9 50-60 500 
Dense HA [75] 1 
compressive: 430-920 
tensile: 17-110 
500 
Tricalcium phosphate 1.3 50-60 900 
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Resorbable bioceramics 
Resorbability is the important parameter in bone tissue engineering. Ceramic scaffold 
should degrade in desired time, i.e. when the newly formed tissue is strong enough 
to withstand the applied load. Unfortunately, no material has fulfilled this criterion yet 
and thus mechanically unstable bone defects have to be temporary stabilized with a non-
resorbable metallic fixation [3]. In that case, the mechanical properties of graft are then 
the minor issue and the most important characteristic becomes the resorption rate 
of the graft. 
Resorption rate of scaffolds is controlled by two main approaches: (1) 
by optimalization of geometry. A key feature is the presence of sufficiently large 
interconnected pores to enable the invasion of blood vessels and cells, hence enabling 
biodegradation of material and bone ingrowth. (2) By modified chemistry, which can 
influence the thermodynamic stability, in particular the solubility [3]. 
 Bioactive glass 
One of the main advantages of bioactive glasses is controlled range of chemical 
properties and thus the rate of bioresorption. It is possible to design the degradation 
properties of glasses specific to a particular application of bone tissue engineering. 
Glasses with compositions in region D of Fig. 10 are being resorbed in tissue within 10–
30 day-long period [72]. 
 Tricalcium phosphate (TCP) 
In the field of calcium phosphate materials, there has been a shift of interest from 
hydroxyapatite, to chemically more reactive compounds such as composites between 
HA and β-tricalcium phosphate (so-called “biphasic calcium phosphates” – BCP), β-TCP, 
α-TCP, octocalcium phosphate (OCP), dicalcium phosphate dihydrate (DCPD) and 
anhydrous dicalcium phosphate (DCP) [3]. 
The dissolution rate of calcium phosphates decreases in the following order:  
Amorphous HA ˃ α-TCP  ˃ β-TCP  ˃ Crystalline HA [29, 76]. 
Calcium phosphate is in vivo resorbed by the action of osteoclasts. These cells can 
dissolved calcium phosphate by local change of pH due to releasing small amounts 
of hydrochlorid acid at the surface [3, 77]. Calcium phosphate is the only type of material 
whose degradation products can be used for new bone formation [3]. 
Tricalcium phosphates (TCP, Ca3(PO4)2 can be found in three modification: α, β and 
α’. α’-TCP exists only above 1430 °C, below the transition temperature it transform into 
α phase. β-TCP is stable at room temperature and transforms to α-TCP at 1125 °C. α-TCP 
is thermodynamically metastable below that temperature, and it can be retained during 
cooling to room temperature. Impurities of Mg, Sr and Zn substituting calcium stabilize 
the β-phase, whereas small amounts of Si substituting phosphorus stabilize the α-phase 
[78].  
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α- and β-TCP have different structure, density and solubility, which determine their 
biological properties and applications. Both are used in several clinical applications: 
β-TCP serves as the component of commercial bioceramics, whereas α-TCP is the major 
constituent of the powder component of bone cement [76]. α-TCP is non-toxic, 
osteoconductive and bioactive ceramics, it crystallizes in the monoclinic space group. 
It is an interesting material due to its biodegradability; it resorbs faster than HA, β-TCP 
and BCP 
Biphasic calcium phosphate combines compounds with different solubility. β-TCP 
resorbs 10-20 times faster than crystalline HA; it takes about six to 18 months [77]. 
The optimal dissolution rate in vivo can be tuned by combination of different ratios of HA 
and β-TCP in BCP.  
2.2.6  Composites 
Composite materials advantageously combine properties of at least two types 
of materials to enhance mechanical and biological properties of the whole scaffold to bring 
it near demands of the host tissue. The dispersed phase is usually harder whereas the matrix 
serves as a stress transfer medium. Composites are categorized into (1) particle- or (2) fibre-
reinforced and (3) structural composites [41]. A prediction of final properties can be made 
by the “rule of mixtures”. Commonly fabricated composites use polymer matrix and ceramics 
as the reinforcing phase. 
Composites demonstrate improved compressive load-bearing capabilities, bioactivity 
and host-implant interface [41]. Different groups of materials can be arbitrarily combined. 
Clinical relevance has mainly the polymer/ceramic system. An advantage of this system is 
optimal elastic modulus which can be comparable with that of bone. The core can be 
polymeric and shell can be ceramic and vice versa.  
Ceramics/polymer composite 
Johnson and Tavakley [79] patented a system with polymeric core (PLA, PGA, PLGA, 
natural polymers) coated with calcium phosphate outer layer which facilitates the cell 
attachment. This composite with a huge surface area can be used as cartilage substituent. 
[80]. Wang et al. [37] studied the hydroxyapatite-polyamide structure with mechanical 
strength comparable to bone. He prepared nano HA/PA porous scaffold by thermally 
induced phase inversion. Another possible approach to obtain composite structure is via 
biomimetic process.  Porous PLLA was soaked in simulated body fluid to allow 
development of apatite throughout the scaffold. The formation of HA was enhanced 
by hydrolysis and nucleation [81]. 
Polymer/ceramic composite can be also easily obtain be soaking of calcium phosphate 
ceramics in adequate polymer such as PGA. If the crack propagates, the polymer matrix 
bridges the strain.  
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Ceramic/ceramic composite  
Various ceramic materials have different properties. Bioactive ceramics is usually weak 
and brittle and vice versa zirconia exhibits outstanding strength and fracture toughness 
even though its surface is nearly inert, leading to in situ slippage. Hence it is convenient 
to coat it by bioactive material such as calcium phosphate. 
Zhang [82] patented ceramic material with gradient structure where elastic modulus 
increased toward the core. Composite was based on (Y-, Mg-, Ce-, Ca-) stabilized zirconia 
which was subsequently infiltrated by glass-ceramic phase. After the infiltration of glass, 
the strength of composite increased three times compared to pure zirconia. This material 
above that, exhibited lower elastic modulus and bioactive surface.  
Kim et al. [83, 84] prepared zirconia foams with bioactive hydroxyapatite layer. 
He overcame the problem with insufficient direct bonding between zirconia and HA 
by more stable fluoroapatite interlayer.  Miao et al. [85] studied zirconia (with addition 
of alumina) with hydroxyapatite-borosilicate glass coatings. The porous ceramics had 
compressive strengths of 5.3 to 36.8 MPa and Young’s moduli of 0.30–2.25 GPa, 
favourably comparable to the mechanical properties of cancellous bones. 
2.3 Ceramic foams – processing techniques 
In the early days of ceramic processing, the goal was to eliminate pores from the ceramic 
structure and thereby partially overcome the Achilles’ heel, inherent brittleness. On the other 
hand, porous (cellular) ceramic materials have many special properties which cannot be 
achieved by their dense counterparts. Ceramic foams are nowadays widely used as ﬁlters, 
absorbents, catalysts and catalyst supports, lightweight structural components and thermal 
insulators [86, 87]. 
 
Fig. 11 Classification of processing methods by pore size [88-90]. 
Fig. 11 gives an overview of processing techniques of porous ceramics: (1) partial 
sintering, (2) sacrificial fugitives, (3) polymer replica technique, (4) direct foaming and (5) solid 
freeform fabrication. 
2.3.1 Partial sintering 
Partial sintering is the simplest method suitable for processing of structures with 
randomly arranged irregular pores (see scheme in Fig. 12).  
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Fig. 12 Scheme of fabrication process by partial sintering [88]. 
Pore size and porosity can be controlled by the pore size of a raw powder and by 
sintering conditions (lower temperature and shorter time than required for full densification 
[88]). The particle size of starting powder should be two to five times larger than the desired 
pore size. The final porosity is usually lower than 50 % [88-90]. The resulting pores are too 
small to allow bone tissue penetrate inside, thus this technique cannot be used separately 
in tissue engineering. However, it can be convenient to combine this method with another 
because the rough surface can help to attach cells or signal molecules [90]. 
2.3.2 Sacrificial fugitives 
Porous ceramics can be fabricated by mixing of an appropriate amount of sacrificial 
fugitives with a ceramic powder, as shown in Fig. 13. The porosity of thus prepared ceramics 
is ranging between 20 % and 90 %, pore size varies between 1 µm and 700 µm, the drawback 
of this method can be poor interconnectivity [89].  
The biphasic composite containing a continuous ceramic matrix and a homogenously 
dispersed sacrificial phase is usually prepared by (1) pressing of a power mixture of the two 
components, (2) slip, tape or direct casting of two-phase suspension, or (3) impregnation 
of previously consolidates preforms of the sacrificial material with a preceramic polymer 
or ceramic suspension [89]. Pore forming agents can be synthetic organic matters (polymer 
beads), natural organic matters (starch, sucrose [91], gelatine, cellulose), inorganic matters 
(nickel, carbon, glass particles, etc.) and liquid (water) [88].  
 
Fig. 13 The scheme of sacrificial fugitive method [89]. 
Organic fugitives are usually extracted by pyrolysis (200 - 600 °C). During this process, 
the huge amount of generated gas can lead to a crack formation, therefore burning rate must 
be slow enough [88]. Ceramic and metallic particles are usually extracted by chemical way 
(e.g. by acidic leaching). Before the removal of the sacrificed template, the continuous matrix 
must be at least partially consolidated. If not, the structure could collapse. Consolidation can 
be achieved by binders, setting agents or alternatively by the sol-gel transition. In case of 
preceramic polymers, the consolidation is achieved by macromolecules linking at 
temperatures slightly below pyrolysis temperature. 
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 Ceramic structure with small pores can be obtained by incorporation of oil into 
aqueous or non-aqueous emulsion by simple agitation or mixing [92]. Very small pores are 
achieved using immiscible liquids having low interfacial energy. The template is subsequently 
removed under mild conditions  [89]. Sacrificial template method can be used for scaffold 
fabrication as well. Descamps et al. [93] prepared gradient structure from TCP and PMMA 
beads by slip casting (Fig. 14). They achieved higher interconnectivity of the pores due to heat 
treatment of PMMA beads. The necks between particles were formed during the dwell 
at 180 °C [93, 94].   
 
Fig. 14 Gradient macroporous foam prepared from β-TCP and PMMA balls of 600-700 µm [93]. 
As was previously mentioned, using liquid as a sacrificial fugitive is very promising. 
An example of this method is freeze casting which is widely used for preparation of bioactive 
scaffolds based on calcium phosphates (microstructure is presented in Fig. 15). 
 
Fig. 15 Microstructure of porous HA samples with 64% porosity [95]. 
The principle of this method is using water or a high-melting point oil (such as 
camphene [96]) as sacrificial material. The suspension is subjected to unidirectional freezing, 
wherein the ice crystals are formed. The dendritically oriented ceramic phase is obtained after 
sublimation of the ice under vacuum [97]. Advantages are following: simple sintering without 
necessity of template burnout, anisotropic morphology, environmentally friendliness. 
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Porosity level is controlled by concentration of suspension, however, it is difficult to obtain 
pores larger than 10 µm [38]. So prepared scaffolds exhibit excellent compressive strength. 
Deville et al. [95] prepared HA scaffolds with unusually high compressive strength: 145 MPa 
at 47% porosity and 65 MPa at 56% porosity.  
2.3.3 Replica technique 
This technique is based on impregnation of a cellular structure with a ceramic slurry 
in order to obtain the ceramic structure exhibiting the same morphology as the original 
template (as shown in Fig. 16). Templates can be either synthetic or natural origin. The method 
was developed in the early 1960s; since then it has become the most popular method and 
that is why it is still extensively used in industry mainly to prepare ceramic filters for molten 
metal filtration.  
 
Fig. 16 The scheme of replica technique [89]. 
Cellular ceramics obtained by this method are characterized by a reticulated structure 
of highly interconnected pores within the range 200 µm to 3 mm. The overall open porosity 
vary between 40 % and 98 %. The smallest pore size which can be achieved by this method 
is limited to 150 µm [86, 88, 89]. 
Synthetic template 
Replicating the polymeric template is the easiest way how to obtain ceramics with the 
desirable pore size. The procedure consists of several steps, the polymeric sponge 
(typically polyurethane) is soaked into a suspension, the redundant suspension is then 
removed by rollers or by centrifuge. The suspension should have an optimal viscosity 
to avoid dripping and simultaneously to be easily partially removed under the shearing 
conditions, in other words, thixotropic behaviour is needed. According to the literature, 
best results were obtain using suspensions which viscosities decreased from 10–30 Pa∙s 
at a shear rate of 5 s-1 down to 1–6 Pa∙s at a shear rate of 100 s-1 [98]. After dipping in the 
suspension, the coated template (see Fig. 17) is being dried and subsequently pyrolysed. 
Heating rates should be lower than 1 °C/min to avoid cracking of the coated struts due 
to decomposition and diffusion of the template material. Binders and plasticizers added 
to the suspension can help the struts to prevent cracking. Colloidal aluminium 
orthophosphate, potassium and sodium silicates, hydratable alumina, colloidal silica, 
polyvinyl butyral and polymerizable monomers are often used as binders. After 
the template-burnout, the ceramics is finally sintered at optimal temperature 
in an appropriate atmosphere. Replica technique can be applied to a variety of materials 
which are able to be dispersed into a suspension. In some cases, mainly in Si-C based 
ceramics, the suspension can be replaced by preceramic polymers [89].  
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Even though this method is quite easy and versatile, the drawback is lower mechanical 
properties than would be expected. It is caused by hollow struts which remain after 
polymer removal during sintering. If the layer is too thin or if the heating rate is not slow 
enough the layer can moreover crack during pyrolysis of the template. It has been made 
several attempts to overcome this disadvantage. As is known, strength increases with wall 
thickness, so the strut size can be increased be repeating the impregnating of the 
polymeric template and drying several times. Alternatively, it is possible to recoat the pre-
sintered ceramic foam by a low viscosity suspension [99]. Strength can be also enhanced 
by immersion of sintered ceramics in a suspension containing colloidal oxides, which can 
due to their small dimension easily penetrate into the structure and there filled micro-
cracks [86].  
 
Fig. 17 Polyurethane sponge impregnated by bioglass [100]. 
Natural templates 
As was previously mentioned, not only synthetic polymer templates can be replicated. 
The main advantage of natural templates is their complicated, often hierarchical, 
morphology which can be hardly produced artificially. Corals have been used as natural 
template since 1970s. Their structure has been replicated through a lost-wax method. 
First step involves impregnation by wax under vacuum. After wax hardening, the calcium 
carbonate is leached out using a strong acidic solution. The negative wax model is 
subsequently impregnated with a ceramic suspension. The organic material is then 
removed by pyrolysis. Another approach is direct conversion of the cellular structure 
of corals into hydroxyapatite by hydrothermal treatments at high temperature and 
pressure. It occurs in a phosphate solution where the carbonate ions from CaCO3 are 
replaced by phosphate ions from hydroxyapatite. 
Another very interesting and for tissue engineering promising approach is to mimic 
structure of wood (see Fig. 18). Anisotropic aligned pores copying oriented vessels 
in the wood are a benefit of this method. The preparation is quite time-consuming 
procedure requiring several steps. First step involves heat treatment of the wood 
structure under inert atmosphere at temperatures within 600–1800 °C. The resulting 
carbon cellular preform is subsequently infiltrated by gases or liquids at high 
temperatures or by liquid sols at room temperatures. The latter approach needs 
subsequent oxidation to render the ceramics. The microstructure of prepared ceramics is 
very close to the original wood template. Pores are much smaller than in case of using 
polymer templates. They vary from 10 up to 300 µm. The porosity is ranging from 25 to 
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95 %. The mechanical properties are anisotropic due to anisotropic structure of wood 
cells. The strength in the axial direction is higher than that in the perpendicular direction. 
Mechanical properties might be degraded similar as in the case of synthetic template due 
to flaws in struts generated during the pyrolysis [89, 101, 102]. 
 
Fig. 18 SEM image of ceramics derived from oak [102]. 
2.3.4 Direct foaming 
The direct foaming is a technique based on incorporation of a gaseous phase into 
a ceramic suspension through mechanical frothing or gas released by chemical reaction. 
The procedure which is illustrated in Fig. 19 allows low-cost and easy production of open or 
close-cells ceramic foams with wide pore size distribution between 10 μm and several mm 
(usually 10 - 300 μm) [89]. Porosity, proportional to the amount of gas incorporated into 
the suspension, lies between 45 % and 95 %. 
Critical issue of direct foaming is the stabilization of the bubbles in the suspension. 
Gas bubbles tend to coalesce in thermodynamically unstable wet foam in order to reduce the 
total Gibbs free energy of the system. To avoid large pores in the final ceramics it is necessary 
to stabilized gas bubbles with surfactants or surface modified particle. Surfactants are 
classified as non-ionic, anionic, cationic or protein. 
 
Fig. 19 Scheme of direct foaming [89]. 
Another direct foaming technique is based on emulsifying a homogeneously dispersed 
alkane or air-alkane phase in the stabilised aqueous powder suspension. Foaming is made due 
to evaporation of alkane droplet.  
Fig. 20 presents three stages of foaming process: (a) alkane emulsion in the powder 
suspension, (b) transition of emulsion to wet foam and (c) transition to stable foam – 
formation of polyhedral structure [103]. 
The advantage of direct foaming is a final structure with dense ceramic struts which 
exhibit only limited amount of defects. For example, compressive strength of alumina can 
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reach about 16 MPa at 88% porosity [88]. By this method it is also possible to prepare porous 
structures with a graded porosity. This method is not suitable for processing of large sample 
sizes because of cracking problems which usually occurs during a drying/sintering step [104].  
 
Fig. 20 Alumina foam prepared by direct foaming of emulsified ceramic powder suspensions [103]. 
2.3.5 Solid freeform fabrication 
Solid freeform fabrication (SFF) (often referred as rapid prototyping) is technique 
which is able to quickly produce complex 3D objects without the need of using moulds or other 
forming tools. Ceramic bodies are formed directly based on data generated by CAD systems. 
An image of a bone defect in a patient can be acquired by e.g. computer tomography. A 3D 
CAD computer model is than developed from this scan. A common feature is that CAD model 
is sliced and ceramic body is build layer by layer [105, 106]. 
The mostly used techniques in rapid prototyping are: (1) 3D printing (3D-P), (2) direct 
ink-jet printing, (3) stereolitography, (4) fused deposition modelling, (5) robocasting and 
(6) selective laser sintering / melting (SLS / SLM). 
3D powder bed printing consists of several steps. Initially, one thin layer of powder, 
such as calcium phosphate is smoothly dispersed on a platform. A suitable binder 
is subsequently inprinted into the powderbed to bind the desired particles within the layer. 
Next layer is dispersed on top of the first layer. The printed binder binds the particles of the 
second layer and to the previous bound layer. The whole scaffold is shaped layer by layer by 
this way. Binder is finally removed at high temperature during consolidation [2]. This 
procedure is exemplified in Fig. 21. 
 
Fig. 21 Solid freeform fabrication: (a) CAD image of porous scaffold, (b) schematic drawing 
representing the 3D printing process [107]. 
SLM technique works on a similar principle with the difference that the particles are 
not bonded by printed binder, but directly sintered using a laser [2].  
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3 AIMS OF THE THESIS 
In accordance with the literature search, the following objectives of the thesis have been 
established. The main goal was to prepare porous ceramic materials with sufficient 
mechanical and biological properties that could potentially serve as substitutes of hard 
tissues. 
To solve this goal, research was divided into the following steps: 
- Development of ceramic foams with hierarchical porosity up to pore sizes 1500 µm 
via replication technique. One approach included composite ceramic scaffolds with 
enhanced mechanical stability due to strong bioinert core based on alumina and/or 
zirconia. The second approach was focused on development of fully bioactive 
ceramic scaffolds based on calcium phosphates. 
- Development of bioactive scaffolds by burning out the organic compounds from in 
situ blown polyurethane / calcium phosphate composite. 
- Study of mechanical and biological properties of the prepared scaffolds. 
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4 EXPERIMENTAL  
4.1 Materials 
4.1.1 Polymer templates 
Reticulated polyester based polyurethane foams with open cell structure were used 
as templates for processing of ceramic scaffolds by polymer replica technique. Commercial 
polymer foams Bulpren (Eurofoam, Czech Republic) of five different pore sizes were chosen 
(see Table 6). Foam structure was entirely open and did not contain any closed cells, same as 
cancellous bone. Templates of different shapes (blocks, cylinders) and dimensions were 
prepared for mechanical and biological testing. 
Table 6 Polymer templates and their characterisation 
4.1.2 Ceramic powders 
Three different oxides and two calcium phosphate commercial powders were used 
in the experiments. 
White fused corundum F1200 (Koltex, Czech Republic), grain size 2.1 µm (sieve sizes of 
FEPA grit F1200). Chemical analysis: 99.5 wt. % Al2O3, 0.07 wt. % Fe2O3, 0.056 wt. % SiO2, 
0.21 wt. % Na2O.  
Synthetic alumina RC HPDBM (Malakoff Ind., US), grain size 0.5 m, specific surface 
area 7.4 m2g-1. Chemical analysis: 50 ppm Fe, 30 ppm Na, 45 ppm Si, 45 ppi Ca.  
Yttria stabilized zirconia HWY5.5 SD (Guang Dong Huawang Materials, China). Specific 
surface area 11 m2/g, grain size 2.8 µm. Chemical analysis: 5.5 wt. % Y2O3, < 150 ppm SiO2, 
< 50 ppm Fe2O3, < 50 ppm TiO2, < 50 ppm Na2O. 
Hydroxyapatite p.a. (Fluka, Switzerland); Ca5(PO4)3(OH), HA, assay ˃ 90%; average size 
of agglomerates 18.5 µm; specific surface area: 33.8 m2/g.  
Beta–tricalcium phosphate p.a. (Fluka, Switzerland); Ca3(PO4)2, assay ˃ 97%; mean size 
of agglomerates 7.7 µm; specific surface area: 1.6 m2/g). 
4.1.3 Binders 
Powders were bonded by polymeric binders (PVA, PVB) or by colloidal solutions 
(AlOOH, SiO2). 
Disperal P3 no.10090 (Condea Chemie GmbH, German), highly dispersible alumina 
powder–boehmite (AlOOH) of grain size 2.6 nm, specific surface area 330 m2/g, chemical 
Type Pores per inch (ppi) Cell diameter (µm) 
Bulpren S 31048 90 440 - 520 
Bulpren S 31062 75 520 - 720 
Bulpren S 28089 60 740 - 1040 
Bulpren S 28133 45 1080 - 1580 
Bulpren S 28190 30 1650 - 2150 
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analysis: 20 ppm Na2O, 100 ppm Fe2O3, 120 ppm SiO2, 4% NO3. 
Ludox SK-R (Grace, U.S.), colloidal silica, average grain size 12 nm; specific surface area: 
230 m2/g, pH 7. 
Butvar B79 (PVB, Solutia Inc., US), 88% polyvinylbutyral, 11% polyvinyl alcohol, 
max 2.5% polyvinyl acetate. 
Polyvinylalcohol – Mowiol 4–88, Mowiol 10–98 and Mowiol 20–98 (Sigma Aldrich, 
Germany). Molecular weight and hydrolysis degree are shown in Table 7. 
Table 7 Types of PVA and their molecular weight and degree of hydrolysis 
 Molecular weight Hydrolysis (mol%) 
Mowiol 4–88 ~ 31,000 86.7—88.7 
Mowiol 10–98 ~ 61,000 98.0—98.8 
Mowiol 20–98 ~ 125,000 98.0—98.8 
4.1.4 Other materials 
Besides powders and binders, other additives such as plasticizers, deflocculate 
or defoaming agents were added to prepare stable suspensions. Diisocyanate and polyol were 
used for in situ blown polyurethane /calcium phosphate composites. 
n-Octanol (C8H18O, Lachema, Czech Republic) used as defoaming agent in PVA 
suspensions. 
Glycerol (Onex, Czech Republic) served as plasticizer in PVA suspensions. 
Dolapix CE64 (Zschimmer Schwarz, Germany). The dispersing and deflocculating agent.   
Ongronat® 2500 MDI (BorsodChem Zrt., Hungary). MDI (2,2' / 2,4' and 4,4'- methylene 
diphenyl diisocyanate) is an aromatic isocyanate and a key polyurethane raw material 
containing 30.5 %NCO. Ongronat is suited for the manufacture of rigid foams, structural foams 
and adhesives.  
Polyol Stepanpol PS-2412 (Stepan Company, US). STEPANPOL PS-2412 is a modified 
phthalic anhydride-based aromatic polyester polyol designed for use in rigid foam 
applications. Hydroxyl number is 230-250 mg KOH/g, water content is max 0.15 wt. %. 
Solvents: isopropanol (p.a.; Lach-Ner, Czech Republic) and deionized water 
(0.1 µS/cm2). 
4.2 Methodology 
All methods used in the experiments described in Chapter 5 are summarized below.  
4.2.1 Characterization of powders, suspensions and sintered scaffolds 
Specific surface area  
Specific surface area, SBET, of the starting and heat treated powders was evaluated via 
nitrogen adsorption by ChemBET 3000 (Quantachrome, USA) device. Specific surface area 
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value can be recalculated into approximate diameters of the ball shaped particles 
according to the equation (3). 
𝐷𝐵𝐸𝑇 =
6
𝑆𝐵𝐸𝑇 ∙𝜌𝑡ℎ𝑒𝑜𝑟
 [𝑚]               (3) 
Thermal analysis 
Thermal analysis, was performed by 6300 Seiko Instruments TG-DTA. 
The measurement was conducted in the temperature range between 35 and maximally 
1200 °C in argon or in a mixture of air and argon in a ratio of 1:1, flow rate was set to 
400 ml / min, temperature increase was 2 °C/min.  
Zeta potential 
Zeta potential, a key indicator of the stability of colloidal dispersions, was measured 
in aqueous dispersions by using Zetasizer 3000 HS (Malvern Instruments, UK).  
Rheological properties 
Viscosity of the prepared sols and slurries was measured using a rotary rheometer 
Mars II Haake (Thermo Scientific, US). Viscosities were determined in concentric cylinder 
arrangement with the shear rate range 0.5–1000 sec-1. 
Particle size distribution 
Distribution of particle sizes was determined by laser diffraction on LA 950 (HORIBA, 
Japan) device. The agglomerates were broken by US before the measuring. 
XRD analysis 
Phase composition before and after sintering was determined by X-ray diffractometers 
SmartLab 3kW (Rigaku, Japan) and PANalytical X'pert (Philips, Netherlands). Evaluation 
of crystallographic structure was carried out by the Rietveld method.  
Scanning electron microscopy 
The morphology of powders and structure of sintered scaffolds were observed using 
scanning electron microscopy (ZEISS Ultra Plus, Germany, Tescan VEGA TS5136XM, Czech 
Republic and Philips XL30, Netherlands,).  
Light microscopy 
The morphology of scaffolds at magnification below 100× was registered by DinoLite 
digital camera AM4115ZTL (DinoLite, Netherlands). 
Porosity 
The porosity of scaffolds was determined by several methods. Total porosity was 
calculated from the geometric volume, the mass and the theoretical density as follows 
[108]: 
𝑃 =
𝜌𝑡−𝜌𝑏
𝜌𝑡
× 100%,                (4) 
where ρt is the theoretical density  and 𝜌𝑏 =
𝑚𝑏
𝑉𝑏
  is the bulk density, mb is the mass of  
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the dry test piece and Vb is the total geometrical volume (the sum of the volumes of 
the solid material, the open pores and the closed pores). 
The bulk density of struts was determined via Archimedes’principle (EN 623-2) with 
distilled water [108].  
Image analysis was used to determine the porosity of struts, the total porosity and 
pore (cell) sizes and their distribution. The samples were embedded in a resin, cut, ground 
and polished by standard ceramographic methods. The pore size was estimated by image 
analysis of scaffold cross-sections. At least four photographs were acquired by SEM for 
each sample. Image analysis was done by ImageJ software (National Institutes of Health, 
US). Fig. 22 gives an overview of image analysis routine. For further analysis it was 
necessary firstly convert image to binary representation by tresholding. The total porosity 
was calculated as the count of pixels that represented pores (black pixels). Pore sizes were 
calculated after the image segmentation by watershed algorithm, a strong tool for 
separating touching convex shapes. Areas of individual sphere cross–sections were 
measured and equivalent diameters were calculated.  
 (a)  (b)  (c)  (d)  
Fig. 22 Overview of the image analysis process: (a) acquired image, (b) threshold image, (c) applied 
watersheld algorithm, (d) identified pores. 
The image analysis data were based on only 2D random sections, pore sizes and their 
distribution in 3D would differ. The real pore size distribution would be broader because 
the spheres are rarely cut in the centre. The true 3D mean pore diameter was determined 
applying simple stereological correction factor 0.785 [109] 
𝐷𝑠𝑝ℎ𝑒𝑟𝑒 =
𝐷𝑐𝑖𝑟𝑐
0.785
= 1.274 ∙ 𝐷𝑐𝑖𝑟𝑐 ,            (5) 
where Dcirc is the average circular segment diameter. 
4.2.2 Mechanical testing 
Compressive strength 
Mechanical properties of prepared foams were determined using a compression test. 
High-Precision Electric Actuator Systems 8862 (Instron, US) equipped with 5 kN load cell 
and precise clip-gauge for the deformation measurement was employed for the loading. 
Samples were inserted between compressive platens where for better load transfer was 
inserted also slice of silicone rubber having thickness of 1 mm. An optical system 
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consisting of Canon D40 camera was sometimes used for recording of damage 
development during loading and fracture mechanism observation. During the test, high 
resolution photos of the specimen side were being taken with the interval of 5 seconds. 
The crosshead speed of 0.5 mm/min was used for loading in all tests. The compressive 
strength was determined from the maximal obtained force. The loading was stopped 
when deformation achieved certain value and debris were further investigated by means 
of light and electron scanning microscopy. 
4.2.3 Biological properties 
Bioactivity testing in SBF solution 
According to Kokubo and Takadama [110], “the essential requirement for a material to 
bond to living bone is the formation of bone-like apatite on its surface when implanted in 
the living body”. The in vivo apatite formation can be reproduced in a simulated body fluid 
(SBF), which is an acellular solution of ionic composition (Table 8) similar to human blood 
plasma however, it lacks many elements such as proteins, CO2, and other organic 
molecules which play an important role in material behaviour in vivo [111]. 
Table 8  Nominal ion concentrations (in mM) of SBF in comparison to the human blood plasma 
[110]. 
 Na+ K+ Mg2+ Ca2+ Cl− HCO3− HPO42− SO42− pH 
Blood plasma 142.0 5.0 1.5 1.5 103.0 27.0 1.0 0.5 7.2–7.4 
SBF 142.0 5.0 1.5 2.5 147.8 4.2 1.0 0.5 7.4 
 
The solution was prepared according to the corrected Kokubo recipe [110]. Briefly, 
8.035 g NaCl, 0.355 g NaHCO3, 0.225 KCl, 0.231 g K2HPO4∙3H2O, 0.311 g MgCl2∙6H2O, 39 ml 
HCl, 0.292 g CaCl2, and 0.072 g Na2SO4 were dissolved one by one in 700 ml H2O at 36.5 °C. 
Tris-hydroxymethyl aminomethane ((HOCH2)3CNH2) (Tris) was added into the solution 
little by little until the pH reached 7.45, then was lower to 7.42 by dropping 1M HCl; this 
was repeated until all Tris (6.118 g) was dissolved. When pH was finally adjusted to 7.40 
at 36.5 °C, solution was cool down to 20 °C and deionised water was added to 1000 ml. 
It was necessary to precisely follow the instructions to avoid precipitation of 
a supersaturated solution. Samples were soaked in SBF at 36.5 °C for 7, 14 and 28 days. 
After removal from the solution and rinsing with deionized water, the samples were dried 
at room temperature. The presence of the apatite layer on the surface (see Fig. 23) was 
examined using scanning electron microscopy and confirmed by energy-dispersive 
spectroscopy.  
  
Fig. 23 SEM image of HA layer created on the surface after immersion in the SBF [111]. 
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The weight of dry test samples was measured before and after the test. The tested 
material was considered as bioactive in case that the apatite layer was formed on the 
surface.  
Cytotoxicity 
Cytotoxicity of materials was tested in vitro using direct contact assay according 
to EN ISO 10993-5 specifications [112]. Scaffolds or dense discs were sterilized in 
autoclave for 20 min at 121 °C. Human osteosarcoma cells of cell line MG63 (from 
European Collection of Cell Cultures) were cultivated at 37 °C in 5 % CO2 in Eagle Minimum 
Essential Medium (EMEM) with high glucose, 1 % L-Glutamine, 1 % non-essential amino 
acids (NEAA), 10 % fetal bovine serum, 1 % antibiotics and 0.3 % gentamicin. Cell line was 
then inoculated into a measured amount of cultivation medium and transferred to the 
surface of material sample with the density of 3 500 cells/cm2 of a cultivation vessel. After 
exposition period (8 or 72 hours) samples were washed by PBS twice and cells were 
fixated and dried by increasing alcohol series. Dried cell-seeded samples were examined 
by SEM. Tolerance of cells towards the tested material was evaluated by calculating the 
percentage of surface colonization [113]. 
Besides cytotoxicity, bioactivity of test pieces immersed in the culture medium was 
evaluated. Minimum essential Medium (MEM) is a cell culture medium with ionic 
concentration similar to SBF. Additionally, it contains the same vitamins, amino acids and 
glucose as blood plasma. The principle of bone-like apatite formation on surfaces of 
tested pieces is analogous to that of SBF solution and can be found elsewhere [114-116]. 
Samples were soaked in a medium for 3 days. The presence of the apatite layer on the 
surface was studied by SEM.  
Cell seeding and cultivation 
Materials were sterilized by UV-irradiation for 20 minutes in flowbox. Samples were 
wet in DMEM-Glutamax (Life Technologies, Czech Republic), medium for 1 hour and 
centrifuged on 800×g to eliminate air bubbles from material.  
Adipose-derived stem cells were isolated from adipose tissue by centrifugation and 
collagenase extraction, as described in [117]. Briefly, adipose tissue was digested with 
0.1% collagenase type IV for 30 min at 37 °C. Following enzyme activity neutralization by 
DMEM-F12 with 10% FBS, cells were separated by centrifugation at 600g. The pellet was 
resuspended in cultivation medium (10% FBS, 0.5% penicillin/streptomycin (GE 
Healthcare Life Sciences, USA) in DMEM Glutamax) and propagated on a culture dish 
coated by 0.01% gelatin. 
Subsequently, cells were trypsinized and seeded on materials at concentration 
of 50.000/100 μl for analysis cell viability and 1 million cells/100 μl for evaluation of cell 
morphology. After 24 hours, samples were taken for analysis after 24 hours of cultivation. 
Analysis of cell viability  
Cell viability was assessed on both materials with porosity 75 ppi by fluorescent 
live/dead assay. Fluorescent stock solution was prepared by dilution of 0.03% w/v 
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acridine orange and 0.1% w/v of ethidium bromide (Sigma-Aldrich, Czech Republic) into 
2% EtOH in distilled H2O, with final dilution 1/1000 in 0.1 M phosphate buffer. Fluorescent 
solution was added to the samples for 5 minutes at room temperature and live/dead cells 
were visualized using epifluorescence microscope Cell^R (Olympus C&S Ltd., Prague, 
Czech Republic). 
Evaluation of cell morphology by fluorescence microscopy 
Cells cultivated for 24 hours on all materials were fixed with 4% paraformaldehyde 
dissolved in 0.1 M phosphate buffer and permeabilized by 0.1% Triton TX-100. Actin 
cytoskeleton was stained with 60 nM Phalloidin Rhodamine (R415, Lifetech, Czech 
Republic) dissolved in 0.1 M PBS and cell nuclei were stained with 1 μg/mL 4′,6-diamidino-
2-phenylindole (DAPI), (Sigma-Aldrich, Czech Republic). Samples were observed with 
epifluorescence microscope Cell^R (Olympus C&S Ltd., Prague, Czech Republic). 
4.3 Ceramic foam processing 
Ceramic scaffolds were prepared by two techniques: by polymer replica technique 
and by burning out of polyurethane from CaP / PU composites prepared in situ from MDI 
and polyol. 
4.3.1 Polymer replica technique 
This procedure was chosen as optimal because of its versatility and the possibility 
to fabricate ceramic foams with open porosity which is one of the fundamental parameters 
in tissue engineering. The formed structure has been closely similar to the structure 
of trabecular bone. 
The key to obtain highly reproducible uniformly covered foams without sealed pores 
was to handle the multistep processing technique which is illustrated in Fig. 24.  In general, 
polymer sponge templates were cut into desired shapes (blocks or cylinders) and 
subsequently immersed into the ceramic suspension (the individual compositions are listed 
in subchapters below this section). The suspension residue was removed by squeezing 
between two extra polymer foams and by application of compressed air. 
           
Fig. 24  A scheme of preparation of ceramic scaffold by replication technique: (a) PU template, (b) 
template coated by suspension, (c) sintered ceramic body 
 Drying 
 Burnout of 
polyurethane 
 sintering 
 Immersion of PU 
foam into ceramic 
suspension 
 Removing of excess 
suspension from 
foam 
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 To achieve lower final porosity, it was possible to repeat this step until desired 
thickness of struts. So-prepared templates were dried at ambient atmosphere for 24 h. 
Then the polyurethane sponge was burnt out at 800 °C or 1000 °C for 2 h with slow heating 
rate (0.5—1 °C/min) to preserve crack formation in a green foam structure. Calcined 
foams were pressureless sintered in air in a superkanthal furnace with increasing rate 
5 °C/min. Some of sintered cores were consequently impregnated by another suspensions 
with aim to fill the hollow struts and thus to enhance mechanical properties. Reinforced 
scaffolds were dried and sintered. The last step in case of bioinert ceramic foams was 
dipping in the calcium phosphate based suspension, drying and sintering. 
As was mentioned above, scaffolds of different composition were prepared by this 
technique. Chemical composition of suspensions, heat treatment and other parameters are 
described in more detail below. 
Alumina based scaffolds 
 PU template: Bulpren S 28190 with initial pore size 30 ppi, 30 × 30 × 30 mm, 
φ 28 × 30 mm 
 Suspension preparation: 
Compositions of studied suspensions are summarized in Table 9.  
Table 9 Composition of suspensions used for alumina scaffolds (“A” in sample 
identification refers to core suspension, “D” and “R” refers to shell layers) 
Suspension Disperal (g) H2O (g) Powder (g) 
A700 1.92 28.08 70.0 (F1200) 
A710 1.86 27.14 71.0 (F1200) 
A720 1.79 26.21 72.0 (F1200) 
A725 1.76 25.74 72.5 (F1200) 
A730 1.73 25.27 73.0 (F1200) 
A740 1.66 24.34 74.0 (F1200) 
D8 8.0 92.0 × 
R35 4.16 60.84 35.0 (RCHP-DBM) 
R50 3.20 46.80 50.0 (RCHP-DBM) 
Suspension Butvar (g) Isopropanol (g) Powder (g) 
HA 0.086 5.61 4.3 (hydroxyapatite) 
 
Alumina core: Disperal was stirred with water at 240 rpm for two hours; 
the subsequent aging took 2, 4, 6, 8, 24, and 430 h. Alumina powder was added 
into the aged colloidal solution. 
Hydroxyapatite shell: Butvar was left to swell in isopropanol for 1 hour. 
The resulting solution mixed with hydroxyapatite powder was ball-milled for two 
hours in polyamide container with zirconia balls to form the suspension. 
 Scaffold processing 
Alumina cores prepared as described in chapter 4.3.1. were reinforced by two 
ways: (1) by infiltration of colloidal dispersion of Disperal (“D10”) for 8, 24, 64, 
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128 h and 5 × 5 h (2) by infiltration of alumina suspension “R35” or “R50”.  
Scaffolds were soaked under reduced pressure to facilitate penetration into the 
pores. 
 Heat treatment: 
Alumina core: PU foam was burnt out at 800 °C for 2 h in air atmosphere. Final 
sintering was carried at 1400, 1500 and 1600 °C for 2 or 4 h in air.  
Disperal / alumina reinforced scaffold: 800 °C/2 h and 1600 °C/2 in air. 
Hydroxyapatite shell on alumina: 800 °C/2 h and 1250 °C/2h in air atmosphere. 
Alumina toughened zirconia based scaffolds 
 PU template: Bulpren S28133 (45 ppi), S 28089 (60 ppi), S 31062 (75 ppi) 
 Suspension preparation: 
Compositions of studied suspensions are summarized in Table 10 
Table 10 Composition of suspensions used for ATZ scaffolds 
Suspension Disperal (g) HWY 5.5SD (g) Water (g) 
ATZ_97.5_0.5 1.78 48.22 50.00 
ATZ_97.5_0.55 1.96 53.04 45.00 
ATZ_97.5_0.6 2.14 57.86 40.00 
ATZ_95_0.5 3.52 46.48 50.00 
ATZ_95_0.55 3.87 51.13 45.00 
ATZ_95_0.6 4.23 55.77 40.00 
ATZ_95_0.65 4.58 60.42 35.00 
ATZ_90_0.5 6.90 43.10 50.00 
ATZ_90_0.55 7.59 47.41 45.00 
ATZ_90_0.6 8.28 51.72 40.00 
Suspension Butvar (g) Isopropanol (g) Powder (g) 
HA_pvb 0.09 5.63 4.28 
β-TCP_pvb 0.11 4.68 5.21 
 
Processing of ATZ suspension: zirconia powder (HWY 5.5SD) was bonded 
by 24hours-aged boehmite sol stabilized by 1 M acetic acid to pH4. 
The suspension was stirred for 1 hour by overhead stirrer. US was applied for 
the last 30 min of stirring to crush agglomerates. 
CaP suspensions: Butvar was left to swell in isopropanol for 1 h, the powders were 
added and suspensions were stirred for 2 h by magnetic stirrer at 240 rpm. 
 Scaffold processing 
ATZ cores were prepared as described in chapter 4.3.1. To achieve different 
porosities, various number of layers was applied. Each layer was dried at 60 °C 
until the constant weight. The coating and drying procedure was repeated until 
the desired number of layers was reached (up to 6).  
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Sintered ATZ foams were soaked in the CaP suspension at reduced pressure and 
the excess slurry was removed by compressed air. This step was repeated twice 
to achieve a homogenous layer.  
 Heat treatment: 
ATZ core: PU foam and other organic residues were burned out at 800 °C for 2 h 
in air (temperature increase 1 °C/min). Sintering was carried out at 1550 °C for 
2 h in air. 
Composites were burned at 800 °C/2 h and sintered at 1200 °C/3h in air 
atmosphere. 
Calcium phosphate based scaffolds 
 PU template: Bulpren S 28133, S 28089, S 31062, S 31048 with initial pore sizes 
45, 60, 75 and 90 ppi. Dimensions: φ 18 × 10 mm; φ 9.2 × 10 mm, 5 × 2 mm 
 Suspension preparation: 
CaP powders were bonded by water solution of polyvinylalcohol. Powder was 
added into solution of polymer binder. The resulting suspension was agitated by 
3D motion generated by Turbula device (Willy A. Bachofen AG – Maschinenfabrik, 
Switzerland) at 98 rpm for 2 h.  
Preparation of water suspension: 5 wt. % PVA (Mow 4-88, 10-98, 20-98), 0.01 – 
0.1 wt% octanol, 0.2–0.5 wt. % glycerol. PVA was allowed to swell in water before 
the addition of octanol and glycerol. The solution was then filled by commercial 
HA or calcined HA powder to achieve weight ratio of 40 to 50 wt. %. 
 Scaffold processing 
CaP scaffolds were prepared as described in chapter 4.3.1. To achieve different 
porosities, various dilution of starting concentration was used or various number 
of layers was applied. Scaffolds were dried at air atmosphere for 24 h.  
 Heat treatment: 
PU template was burnt out at 1000 °C for 2 h with heating rate 0.5 °C/min, 
scaffold was finally sintered at 1100 °C/2 h, 1150 °C/2 h, 1200 °C/3h, 1250 °C/3h 
and 1400 °C/3h in air. 
Calcium Phosphate based scaffolds reinforced by silica 
 PU template: Bulpren S 28133, S 28089 S 31062, S 31048 with initial pore sizes 
45, 60, 75 and 90 ppi, φ 9.2 × 10 mm for mechanical and φ 5 × 2 mm for biological 
tests. 
 Suspension preparation: 
HA powder was bonded by colloidal silica solution Ludox. Various HA/SiO2/water 
ratios were tested. Starting compositions are summarized in Table 11. The 
suspensions were subsequently water diluted according to the pore size of the 
template. 
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Table 11 Compositions of HA/SiO2 suspensions 
 HA powder (g) Ludox SK-R (g) Water (g) 
HA 95 SiO2 5 10 1.97 8.03 
HA 90 SiO2 10 10 4.17 5.83 
HA 85 SiO2 15 10 6.62 3.38 
HA 80 SiO2 20 10 9.37 1.00 
 
Powder was added into the water and Ludox mixture. The resulting suspension 
was agitated by 3D motion generated by Turbula device (Willy A. Bachofen AG – 
Maschinenfabrik, Switzerland) at 98 rpm for 2 h.  
 Scaffold processing 
HA/SiO2 scaffolds were prepared as described in chapter 4.3.1. To achieve 
different porosities, various dilution of starting concentration was used. Scaffolds 
were dried at ambient atmosphere for 24 h.  
 Heat treatment: 
PU template was burnt out at 1000 °C for 2 h with heating rate 0.5 °C/min, 
scaffold was finally sintered at 1200 and 1250 °C/3h in air. 
4.3.2 CaP scaffold prepared from rigid polyurethane foam 
Ceramic foams described in this chapter were again obtain by burning out of the 
organic content from polyurethane / CaP composite. The difference compared to previous 
chapters was that the composite foam was polymerized in situ. The main advantage of this 
approach was supposed to be an increase of the strength due to fully filled ceramic struts. 
Preparation of the composite foams  
Porous polyurethane / CaP composite scaffolds were produced by the reaction 
between the polyisocyanate ONGRONAT 2500 and the polyol STEPANPOL PS-2412. 
The detailed compositions of the prepared mixtures can be found in Table 12, where 
the sample name is created as follows: type of powder, powder/polyurethane ratio in 
%_H2O in pphp (parts per hundred polyol)_isocyanate index. 
The required quantities of the polyol, deionized water and powder were rigorously 
mixed in a mortar for 5 min. The isocyanate was then added into the same mortar 
and mixed until achieving a homogenous texture (maximally for another 1 min). If the 
powder/polyol ratio was higher than 2.3 (resp. 2 for uncalcined powder) the excess 
powder was added into the diisocyanate before the final mixing. The resulting mixture 
was immediately put into a mould and left there for 24 hours to allow the formation 
and growth of the composite foam. 
Table 12 Compositions of studied composite foams 
Sample polyol (g) water (mg) MDI (g) CaP powder (g) 
HA100_0_105 3.09 0 1.91 5 (HA calcined) 
HA100_1_105 2.79 28 2.18 5 (HA calcined) 
HA100_2_105 2.55 51 2.40 5 (HA calcined) 
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HA100_3_105 2.35 70 2.58 5 (HA calcined) 
HA100_4_105 2.17 87 2.74 5 (HA calcined) 
HA100_5_105 2.02 101 2.88 5 (HA calcined) 
HAu100_0_105 3.09 0 1.91 5 (HA uncalcined) 
HAu100_2_105 2.55 51 2.40 5 (HA uncalcined) 
HAu100_4_105 2.17 87 2.74 5 (HA uncalcined) 
HA62_0_105 3.09 0 1.91 3.09 (HA calcined) 
HA56_1_105 2.79 28 2.18 2.79 (HA calcined) 
HA51_2_105 2.55 51 2.40 2.55 (HA calcined) 
HA47_3_105 2.35 70 2.58 2.35 (HA calcined) 
HA43_4_105 2.17 87 2.74 2.17 (HA calcined) 
HA40_5_105 2.02 101 2.88 2.02 (HA calcined) 
HA100_2_75 2.96 59 1.98 5 (HA calcined) 
HA100_2_85 2.81 56 2.14 5 (HA calcined) 
HA100_2_95 2.67 53 2.27 5 (HA calcined) 
HA100_2_115 2.44 49 2.51 5 (HA calcined) 
HA100_2_125 2.34 47 2.62 5 (HA calcined) 
HA40_2_105 2.55 51 2.40 2 (HA calcined) 
HA60_2_105 2.55 51 2.40 3 (HA calcined) 
HA80_2_105 2.55 51 2.40 4 (HA calcined) 
HA120_2_105 2.55 51 2.40 6 (HA calcined) 
HA40_4_105 2.17 87 2.74 2 (HA calcined) 
HA60_4_105 2.17 87 2.74 3 (HA calcined) 
HA80_4_105 2.17 87 2.74 4 (HA calcined) 
HAu61_0_107 6.11 0 3.89 6.13 (HA uncalcined) 
TCP74_0.5_95 9.16 45 5.80 11.12 (TCP) 
HAu61_0.5_108 6.08 30 3.89 6.11 (HA uncalcined) 
 
After the curing, the green body was removed from the mould and cut into 
the required shapes. The organic contents were burnt out in air at 800 °C for 2 hours 
(or 1050 °C/2 h) with a slow heating rate 0.5 °C/min. The ceramic scaffolds were finally 
sintered at 1050 °C/2 h, 1200 °C/2 h and 1350 °C/2 h in air atmosphere with a heating and 
cooling rate 5 °C/min.  
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5 RESULTS AND DISCUSSION 
5.1 Bioactive ceramics based on alumina core 
5.1.1 Characterization of suspensions 
The rheological behaviour of sols and suspensions was studied in order to find 
suspension with optimal adhesion to PU template, optimum stability and high cover efficiency. 
As shown in Fig. 25 the viscosity of 6 wt. % sol of Disperal was influenced by time of aging. 
When the aging time increased, the viscosity decreased. The shear thinning behaviour 
occurred in lower shear stresses in the case of shorter aging time (2 and 4 h). The Newtonian 
behaviour was observed after 6 h of aging. Nevertheless, the optimal aging time was 
determined to 24 h, when the supposed de-agglomeration of powder was finished and sol 
was stabilised with almost Newtonian rheological behaviour. 
 
Fig. 25 Rheological behaviour of 6 wt. % dispersal sol 
In order to optimize replica method, 24 h aged Disperal sol was filled with different 
amount of alumina. Fused and milled alumina powder was chosen for core layer to prevent 
unfavourable shrinkage during sintering. As shown in Fig. 26, the suspensions with various 
alumina content (from 71 to 73 wt. %) exhibited shear-thinning behaviour; viscosity increased 
with increasing alumina content. A thixotropic behaviour of all alumina suspensions was 
observed in lower shear stresses. Shear thinning behaviour was in accordance with previously 
published works [99, 118]. Coating behaviour was further important parameter for 
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determination of optimal composition of suspension. Suspension with 72.5 wt. % of alumina 
revealed an optimal adhesion to PU foam with low degree of sealed struts of foam. 
 
Fig. 26 Concentration dependence vs. rheological behaviour of fused alumina suspensions 
5.1.2 Foam characterisation  
The macrostructure morphology of prepared foams, after taking into account 
the shrinkage, was almost the same as one of PU template that was replicated. As is evident 
from Fig. 27 prepared foams were highly porous without sealed walls of scaffold cells (pores). 
The average scaffold cell size was 3539 ± 218 μm. The average size of pores that connected 
cells, sometimes referred as “cell windows” was about 1200 μm. Detail dimensions for various 
compositions are summarized in Table 13. Thickness of hollow struts varies between 260 and 
370 μm. The triangular void in the centre of strut (see Fig. 29a) is a main drawback of replica 
method, because it negatively influences the mechanical properties of foam [89].  
 
Fig. 27 Macrostructure of alumina foam (A7250) 
Two methods of filling of the struts were tested: (1) soaking in 8 wt. % Disperal sol for 
different time periods and (2) coating by shell layer composed of Dispersal sol and chemically 
synthetized alumina powder with smaller particles than the fused and milled alumina 
particles. Particle size distribution of used powders is given in Fig. 28. Combination of three 
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different alumina powders with particle size varied from nano to micro had a crucial influence 
on final properties of foams such as density, porosity and mechanical properties [119].   
 
Fig. 28  Particle size distribution of alumina powders 
Pore size, porosity and density of alumina foams before and after infiltration 
of Dispersal sol are summarized in Table 13. The density of strut material slightly increased 
with increasing alumina content. However, this trend was not confirmed by image analysis, 
where, taking into account standard deviation, the porosities were almost the same. Results 
indicate that long soaking time had a positive influence on density of strut material. 
Table 13 Summary of obtained porosities and densitis of foam composites 
 
sample Wt. % 
Time of 
infiltr.  (h) 
Total 
porosity (%) 
Pore size („cell window“) (μm) 
Porosity 
of strut 
mat.  (%) 
Archimedes 
density 
(% ρtheor.)  min max mean 
A7100 71 0 95.1 314 2350 1134 46.03 51.97 ± 0.63 
A7107 71 168 93.1 234 2603 1168 39.64 — 
A710X 71 5x5 93.2 290 2401 1265 43.22 — 
A7200 72 0 95.3 190 2127 1021 48.21 53.22 ± 0.14 
A7207 72 168 93.4 276 2687 1112 33.84 — 
A720X 72 5x5 92.3 234 2537 1105 37.99 — 
A7250 72.5 0 95.5 262 2453 1199 46.97 53.15 ± 0.31 
A7257 72.5 168 94.9 205 2329 1108 29.95 — 
A725X 72.5 5x5 93.4 294 2635 1361 43.88 — 
A7300 73 0 93.3 208 2370 1158 49.28 54.44 ± 0.64 
A7307 73 168 92.9 414 2952 1431 31.66 — 
A730X 73 5x5 91.7 280 3088 1498 47.89 — 
 
Influence of infiltration of Disperal sol on struts morphology is illustrated in Fig. 29. 
The figure on the left illustrates the cross-section of foam based on fused alumina, the middle 
cross-section was obtain after 168 h infiltration and on the right side, there is the cross section 
of foam which was soaked 5 times for 5 hours. It is evident that the hollow voids inside the 
struts were not completely filled with nanosized alumina, nevertheless, the repeating drying 
after 5 hours cycles had positive effect on the strut morphology. It was the interesting result 
because density evaluated by means of image analysis showed that density increased more 
significantly in the case of very long soaking time –  after 168 h as is illustrated in Fig. 30. Small 
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alumina particles are visible inside the pores but is evident that neither pores were filled 
completely. 
    
 
Fig. 29 Cross-section of alumina core (a) before soaking in Disperal sol and (b) after soaking 
in Disperal sol 168 h and (c) after 5× soaking in Disperal sol for 5 hours  – newly formed small 
alumina particles are visible in pores 
 
 
Fig. 30 Microstructure of alumina strut A725 (a) before soaking in Disperal sol; (b) after soaking in 
Disperal sol – newly formed small rounded alumina particles are visible in pores 
On the contrary, the strut was completely filled by second approach, by coating by 
microsized synthetized alumina (Fig. 31). To improve the bioactive behaviour, the bioactive 
calcium phosphate surface layer was applied on cores reinforced by this approach—by 
synthetized alumina, as can be seen in Fig. 32. As is evident, the layers are strongly bound to 
each other. The thickness of each layer (synthetized alumina and hydroxyapatite) was about 
20 μm. 
 
Fig. 31 Detail of core strut filled by synthetic alumina 
a) b) c) 
a) b) 
41 
 
 
 
Fig. 32 Microstructure of composite (from right to left: alumina core, alumina shell and 
hydroxyapatite layer) 
5.1.3 Biological properties – bioactivity testing in simulated body fluid 
Biological properties were evaluated by means of bioactivity testing in simulated body 
fluid. After 14 days of soaking in SBF, the surface of the scaffold was partially covered by newly 
formed apatite layer in typical cauliflower morphology consisted of thin lamellae as is 
illustrated in Fig. 33. The formation of bone-like apatite on the surface of alumina / alumina / 
hydroxyapatite scaffold after soaking in SBF was attributed to the ion exchange between HA 
compacts and the SBF solution. 
   
Fig. 33 Surface of alumina / alumina / hydroxyapatite scaffold after 14 days immersion in SBF: 
(a) typical cauliflower like structure of newly formed apatite; (b) detail of thin lamellae. 
a) b) 
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5.1.4 Mechanical properties 
Resistance of prepared foams to the mechanical loading were characterised by 
compressive strength. The overview of the compressive strength values on the used 
preparation parameters is plotted in Fig. 34.  
 
Fig. 34 Compressive strength of alumina foams reinforced by boehmite sol in dependence of various 
soaking times. 
From this dependence a change of mechanical resistance with both the soaking time 
and the concentration of suspension used for the infiltration is visible. The short soaking time 
and/or suspensions with low powder content exhibited low compressive strength due to non-
homogenous and insufficient infiltration of the core layer. On the other hand, suspensions 
having higher powder content exhibited enhancement of compressive strength. Therefore, 
the optimal processing conditions were chosen for the powder content of 72.5 wt. % and the 
soaking time 168 h or 5 × 5 h.  
Nevertheless, the compressive strength values seemed to be quite low. It was caused 
by very high porosity of testing samples which exceeded 92 %. The strength is exponentially 
proportional to the porosity, hence 5% reduction of porosity by coating of shell layer had 
positive effect on mechanical stability of the prepared foams. The compressive strength of 
core-shell type specimens are displayed in Fig. 35. The maximum strength increased to 
1.2 MPa. 
 
Fig. 35 Compressive strength core-shell alumina composites. A725 – alumina core; A725_R35 – 
alumina core / alumina shell (35 wt. %); A725_R50 – alumina core / alumina shell (50 wt. %);  
Basically two fracture mechanisms were observed. The first one exhibited separate 
fracture of individual struts in the area of contact between sample and compressive platens. 
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This fracture behaviour was observed in samples with lower compressive strength and typical 
example of loading curve is displayed in Fig. 36a and corresponding images before and after 
the test are below the loading curve in the same figure. The different fracture mechanism was 
observed during loading of samples having higher compressive strength where the damage 
occurred in the whole specimen volume. Usually the final fracture was comparable with 
typical fracture behaviour of bulk and loading trace exhibits sudden drop of load. The example 
of loading trace is displayed in Fig. 36b and corresponding images before and after the tests 
can be found below the curve.  
  
 
Deformation 0% 
 
Deformation 15% 
 
Deformation 0% 
 
Deformation 4% 
Fig. 36 Fracture behaviour under applied stress: (a) separate fracture of individual struts; 
  (b) fracture in the whole specimen volume 
5.1.5 Summary of Chapter 5.1 
Open-cell alumina foams were prepared by replica technique from fused alumina 
powder bonded by boehmite sol. Porous cores exhibited low compressive strength (<0.3 MPa) 
due to high total porosity (93–96%), low microstructure density (~ 50%) and because of 
triangular voids inside the strut which could act as stress concentrators. The strength of 
ceramic cores was doubled as a consequence of soaking in boehmite sol. The density of strut 
material after soaking was slightly higher than before, even though the struts remained 
partially unfilled. The second approach, soaking in suspension composed of boehmite and 
synthetized alumina powder, lead to completely filled struts. The compressive strength 
increased about fourfold. The reinforced alumina / alumina composite foams were coated by 
hydroxyapatite suspension to shift bioinert behaviour to bioactive one. All layers seemed to 
firmly adhere to each other. After 14-day-long incubation in SBF, the newly formed layer 
of apatite was precipitated on the surface of composite scaffold. For potential application 
in  tissue engineering it would be necessary to reduce pore sizes to maximally 500 μm and 
simultaneously enhances the compressive strength, e.g. by decreasing  porosity below 85 %.  
a) b) 
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5.2 Bioactive ceramics based on alumina toughened zirconia 
Bioactive ceramics described in this chapter were composed of zirconia inorganically 
bonded by boehmite (AlOOH). The amount of alumina in the structure after sintering varied 
between 2.5 and 10 wt. %. Alumina was not added to increase fracture toughness because 
zirconia powder was toughened by stabilisation of tetragonal phase by 3 mol % of yttria. 
The alumina was added because it was reported that it prevents zirconia from unfavourable 
low temperature degradation in body environment [120] and to improve properties 
of interface between zirconia and bioactive calcium phosphate based layer. 
5.2.1 Characterization of suspensions and sintered scaffolds 
Thermal analysis 
Thermal analysis was carried out to determine the amount of Al2O3 generated by 
decomposition of commercial boehmite powder. The TG curve (Fig. 37) indicated a total 
mass loss of 30.5 %. This value was slightly higher than 28% mass loss reported by 
the manufacturer. The higher measured loss was probably caused by physically adsorbed 
water. Boehmite was decomposed to alumina and water according to the following 
equation:     2𝐴𝑙𝑂𝑂𝐻 → 𝐴𝑙2𝑂3 + 𝐻2𝑂               (6) 
 
Fig. 37 Thermal analysis of commercial boehmite sol Disperal P3 
Zeta potential 
Zeta potential, a key indicator of the stability of colloidal dispersions was measured 
in aqueous dispersion of Disperal P3. Colloids with low absolute value of zeta potential 
(-30 mV to +30 mV) are not efficiently electrically stabilized and tend to coagulate. As is 
evident from Fig. 38, the dispersions in acidic range behave stably, the highest ζ-potential 
equalled to +60 mV was measured at pH 4, and therefore the pH of prepared sols was 
adjusted by acetic acid to this value in the following experiments. 
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Fig. 38  ζ-potential as a function of pH for the dispersion Disperal P3. 
Viscosity of suspensions 
Suspensions were prepared from 24 h aged boehmite sol which rheological properties 
were described in Chapter 5.1.1.  
The viscosity dependence on the shear rate is illustrated in Fig. 39. Viscosity 
of suspensions increased with increasing content of solid phase almost 20 folds. 
The prepared suspensions moreover exhibited slightly thixotropic behaviour, therefore it 
was necessary to stir the suspension at a constant speed of 240 rpm during a template 
coating. 
 
Fig. 39 Effect of shear rate and suspension concentration on viscosity 
 From a technological point of view, the best results for the scaffolds with pore sizes 
equal to 45 ppi were achieved when suspension contained 60 wt. % of solid phase. 
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However, this suspension was too viscous for coating of scaffolds with smaller pores. 
To avoid undesirable blocking of open scaffold cells (“macropores”), the scaffolds with 
60 ppi and 75 ppi porosity were coated by suspension containing 50 wt. % of solid phase. 
 
Morphology of sintered scaffolds 
Ceramic foams of different total porosity and pore size were prepared by coating of 
various templates several times. Morphology parameters of sintered scaffolds such as 
total porosity, strut thickness, cell size and size of windows between adjacent macrocells 
(pore size) of prepared scaffolds are summarized in Table 14.  
Table 14 Porosity, strut thickness, cell size and pore size of ATZ scaffolds 
PU porosity n layers Porosity Strut thickness (µm) Scaffold cell size (µm) Pore sizes (µm) 
45 ppi 1 layer 98.3 ± 0.7 100 ± 18 1260 ± 423 496 ± 334 
45 ppi 2 layers 93.3 ±0.6 146 ± 35 1258 ± 390 476 ± 328 
45 ppi 3 layers 88.7 ± 1.7 169 ± 40 1166 ± 379 442 ± 284 
45 ppi 4 layers 78.6 ± 1.9 274 ± 71 990 ± 336 336 ± 243 
45 ppi 5 layers 63.5 ± 1.5 395 ± 131 — — 
45 ppi 6 layers 52.1 ± 2.3 — — — 
60 ppi 1 layer 96.8 ± 0.5 73 ± 17 745 ± 316 375 ± 226 
60 ppi 2 layers 91.6 ± 0.9 98 ± 27 721 ± 244 320 ± 166 
60 ppi 3 layers 80.3 ± 2.6 ca 296 ± 159 — — 
60 ppi 4 layers 61.5 ± 2.3 ca 340 ± 165 — — 
 
It is evident, that the initial porosity of the polymeric template had a crucial influence 
on the final scaffold cell size after sintering. Scaffold cell size corresponded to the cell size 
of polyurethane foam reduced by shrinkage. With an increasing number of layers, the 
average thickness of struts grew from 73 µm to 395 nm. The typical reticulated 
morphology was lost as porosity decreased below 70 % (in the case of larger pores – 
45 ppi) and below 80% (for 60 ppi). Overview of macrostructures of prepared scaffolds is 
shown in the Fig. 40. 
 
Fig. 40 Dependence of porosity on the number of layers. 
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Alumina toughened zirconia substrates with desirable porosity were coated by calcium 
phosphates in order to improve the biological properties of scaffolds. Scaffolds consisted 
of 2 layers of ATZ (5% Al2O3) and CaP coating are shown in Fig. 41. The thickness of 
bioactive layer achieved 20 to 60 µm. The struts of ATZ cores were not filled by HA due to 
closed porosity. 
   
Fig. 41 Structure of the bioactive coatings: (a) a strut with HA coating; (b) cross section of ATZ 
scaffold coated by HA; (c) cross section of ATZ scaffold coated by β-TCP. 
5.2.2 Mechanical tests 
Resistance of some ATZ scaffolds to the mechanical loading was characterised by 
compressive strength. The overview of compressive strength values of ATZ scaffolds 
containing 2.5 to 10 wt. % of alumina is plotted in Fig. 42. It was experimentally confirmed 
that strength decreases with increasing porosity. Material containing 5 % of alumina exhibited 
highest strength, so this composition was chosen for subsequent biological testing. All tested 
samples exhibited strength above 0.2 MPa, the minimal value reported for highly porous 
cancellous bone [121]. Scaffolds for potential load bearing applications in bone tissue 
engineering should have higher density than at least 2 MPa to ensure sufficient strength to 
withstand forces generated in the body. 
 
Fig. 42 Compressive strength of ATZ scaffolds 
a) 
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5.2.3 Biological properties 
Interaction with SBF 
The typical globular morphology of newly formed apatites were locally observable 
on bioactive coatings after 7 days of soaking in SBF. After 14 days, the areas containing 
apatite widespread. After 28 days of soaking, the surface was completely covered by 
a self-grown apatite layer. The top view of ATZ substrate and Ca-phosphates coatings 
before and after 28 days of soaking in SBF is reported in Fig. 43. No change was observed 
on uncoated ATZ samples.  
 
Fig. 43 Microstructure of the substrates and coatings before and after soaking in SBF. 
Cytotoxicity test 
Although both zirconia and alumina are consider being bioinert in contact with host 
tissue, the cytotoxicity of the composite was for sure evaluated by direct contact assay. 
Direct contact between MG-63 cells and all tested materials did not induce any adverse 
effect, cells retained characteristic morphology of MG-63 cells (see Fig. 44.).  
SEM was used to study the adhesion and spreading of MG63 cells on the ATZ / Ca-P 3D 
scaffolds. Micrographs revealed that cells were attached to the pore walls both inside 
(Fig. 44a) and outside (Fig. 44b) of the 3D structure. These results indicates that cells were 
able to migrate through 3D structure of composite having the 1200 μm large pores. 
  
Fig. 44 Cell line MG-63 adhered to the scaffold: (a) on inner struts; (b) on outer struts. 
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A large number of filopodia stretched out from the cells (Fig. 44b) indicated a good 
adhesion to the calcium phosphate surface [122]. The cell density and shape did not differ 
significantly from that observed for the negative control. The smallest amount of cells 
(1850 cells / cm2) adhered to the uncoated ATZ, the largest number of cells (3050 cells / 
cm2) was observed on the surface of β-TCP ceramic (see Fig. 45). This result confirmed 
that all tested materials (ATZ, HA, β-TCP) were cytocompatible and could be used in tissue 
engineering applications. 
 
Fig. 45 Cell density adhered on ATZ 
5.2.4 Summary of chapter 5.2 
Alumina toughened zirconia scaffolds were prepared from 3 mol% yttria stabilised zirconia 
and colloidal boehmite. Pore sizes of interconnected macroporous scaffolds varied between 
350 and 1200 μm. Based on results of the mechanical testing, 5 wt. % content of alumina was 
chosen as optimum for further experiments. Scaffolds of various total porosity (57–98%) were 
fabricated by multiple coating process (up to 6 repeating). The bioactivity of the composite 
scaffold was improved by coating of calcium phosphate based suspension. Two powders were 
used – hydroxyapatite and β-TCP. After 28 days in SBF, newly precipitated apatite was 
observed on both calcium phosphates coatings. Besides bioactivity and cytotoxicity tests, the 
cell colonization of 3D scaffold was evaluated. It was shown, that after three days long 
cultivation MG-63 cells migrated through the scaffold with 1000 μm large pores, the same 
amount of cells was found both adhered to the outer and inner struts of scaffold.  
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5.3 Calcium phosphate scaffolds 
Several types of polymer binders were tested in order to achieve a reticulated calcium 
phosphate foams. However prepared scaffolds had mostly insufficient strength due to high 
porosity (> 90%). Scaffolds prepared from alcohol suspensions had many defects in the 
structure, probably as a consequence of fast evaporation of alcohol. The best scaffolds were 
obtain with water suspension bonded by 5 wt._% of PVA. These results are summarized and 
compared with silica reinforced scaffolds in the Chapter 5.4. 
    
Fig. 46 Structure of calcium phosphate scaffolds sintered at 1200 °C/3 h: (a) template 90 ppi, 
(b) template 75 ppi 
5.4 Calcium phosphate scaffolds reinforced by silica 
Even though the gold standard for restoring bone defects is still considered to be 
autologous bone grafting, there is a strong need for synthetic graft development [123-127].  
Greatest similarity with bone mineral have ceramic materials based on calcium phosphates. 
Their wide expansion into clinical practice is, however, limited by insufficient mechanical 
properties. The objective of this chapter was to develop a material with higher strength and 
at least similar biological characteristics as hydroxyapatite. The idea was to prepare ceramic 
composite material containing calcium phosphate and some reinforcing phase. The choice fell 
on silica because silicon (as Si4+ ion) is consider to be one of the essential trace elements 
required for development of healthy bones. It acts as a biological cross-linking agent 
in extracellular matrix (ECM). On top of that, it enhances osteoblast proliferation, 
differentiation and collagen production [57]. It is claimed that silicon substituted calcium 
phosphate ceramics provide superior biological performance to their stoichiometric 
counterparts [128].  
The effect of silica as a binder and reinforcing phase was studied in this part of the thesis. 
The morphology, mechanical and biological properties were evaluated and compared with 
literature and with characteristics of unreinforced Ca-P scaffolds. 
5.4.1 Characterisation of scaffolds – processing parameters 
Since polymer replica technique was used, ceramic foams were obtained by burning 
the polyurethane templates. The thermal analysis was carried out to understand 
the decomposition process and to determine the temperature at which the complete burnout 
a) b) 
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of the commercial polyurethane occurred in the composite system containing PU (10 wt. %), 
HA (81 wt. %) and SiO2 (9 wt. %).  
TA curves of the studied foam are given in Fig. 47. The little weight loss at the beginning 
of the TA plot, i.e. from 40 to 200 °C was mainly due to moisture evaporation. Afterwards, the 
two stage thermal decomposition process of polyurethane was observed between 200 °C and 
550 °C. Shape of exothermic DTA curve in the temperature range 200 to 550 °C indicates that 
the degradation processes of polyurethane occur by oxidation mechanism. 
The typical two-stage decomposition behaviour was described in various studies [129-
132]. Cakic explained the thermal degradation of PU as primarily a depolycondensation 
process, which started at about 200 °C [133]. At this temperature hard segments (related to 
urethane links) had started to decompose [134], while the second step of degradation (350–
550 °C) had been caused by degradation of soft segments (related to the ether group) [134].  
Experimental data suggest that the weight loss of the sample continued even above 
the temperature of 550 °C at which the polyurethane should have been already burned. This 
was likely caused by thermal degradation of hydroxyapatite which is described in detail in the 
chapter 5.5.1. The endothermic drop on DTA curve around 800 °C also corresponded to the 
thermal decomposition of HA as can be seen in thermogram which is depicted in Fig. 61. 
The total 15% weight loss corresponded to the initial amount of polyurethane 
in the composite (10 %), amount of adsorbed water (1 %) and to 5% weight loss of commercial 
hydroxyapatite after its calcination (4 % relative to the composite).  
 
Fig. 47 TA curves of commercial reticulated PU foam coated by HA-10SiO2 suspension 
5.4.2 Phase composition 
X-ray diffraction patterns in Fig. 48 indicates that all products of thermal reaction were 
crystalline. The XRD spectra illustrated that the hydroxyapatite was totally decomposed into 
α and β–TCP even at 1200 °C. Traces of tetracalcium phosphate identified in the structure 
were a result of HA decomposition, according to the following equation [135, 136]: 
𝐶𝑎10(𝑃𝑂4)6(𝑂𝐻)2
−𝐻2𝑂
→   𝐶𝑎10(𝑃𝑂4)6𝑂
 
→ 2𝐶𝑎3(𝑃𝑂4)2 + 𝐶𝑎4(𝑃𝑂4)2𝑂        (7) 
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If the concentration of silica in the tested sample was low (5 wt. %), walstromite 
(CaSiO3), an isomorph of wollastonite, was distinguishable in the pattern. With increasing 
concentration of silica in the sample, one strong peak at about 21.7° increased. That suggests 
that silica was transformed to the cristobalite crystalline phase (of P41212 space group). 
An approximate weight percentage of phases is listed in Table 15.  
Table 15 Phases present in the scaffolds after heat treatment at 1200 °C (HA) and 1250 °C (HA-SiO2) 
 
α–TCP  
(wt. %) 
β–TCP  
(wt. %) 
Cristobalite 
(wt. %) 
Other phases  
(wt. %) / type 
α : β–TCP 
HA 50.6 49.4 – – 1.02 
HA_5% SiO2 60.8 34 2.3 2.9 (walstronite) 1.79 
HA_10% SiO2 62 25.3 12.7 – 2.45 
HA_15 % SiO2 59.3 21.1 17.4 2.2 (Ca4(PO4)2O) 2.81 
HA_20 % SiO2 65.2 12.5 20.3 2 (Ca4(PO4)2O) 5.22 
 
 
 
Fig. 48 X-ray diffraction patterns of scaffolds containing 5–20 wt. % SiO2, sintered at 1250 °C for 3h 
and HA sintered at 1200 °C for 3h 
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Results indicated that the ratio between α–TCP and β–TCP increased with increasing 
amount of silica. Various researchers [78, 128, 137, 138] confirmed that addition of silica 
shifted the temperature of HA→ α–TCP transformation to lower value.  The stable α–TCP 
polymorph could be even formed during sintering above 700 °C [137-140] [128]. It was further 
reported that hydroxyapatite sintered in the presence of silica tended to transform to silica 
substituted tricalcium phosphate (Si–α–TCP) of formula Ca3(P1-xSixO4-x/2)2 [128, 140]. Having 
the same space group, the Si substituted α–TCP can be distinguished from its stoichiometric 
counterpart via different lattice parameters [128, 140]. Measured and theoretical (α–TCP, 
Si-α–TCP) lattice parameters are compared in Table 16. 
Table 16 Crystallographic parameters of pure and silicon substituted calcium phosphate phases 
Phase Lattice parameters Space 
group 
Ref. 
Measured α–TCP a = 12.880 Å; b = 27.291 Å; c = 12.878 Å; β =107.36° P21/c – 
Measured Si–α–TCP a = 12.843 Å; b = 27.337 Å; c = 12.856 Å; β =107.38°  P21/c – 
Calculated α–TCP a = 12.878 Å; b = 27.291 Å; c = 15.257 Å; β = 126.32° P21/a – 
Calculated Si–α–TCP a = 12.856 Å; b = 27.337 Å; c = 15.218 Å; β = 126.35° P21/a – 
α–TCP a = 12.887 Å; b = 27.280 Å; c = 15.219 Å; β = 126.20° P21/a [141] 
Si–α–TCP (0.87 wt% Si) a = 12.875 Å; b = 27.372 Å; c = 15.225 Å; β = 126.30° P21/a [140] 
Si–TCP a = 12.863 Å; b = 27.357 Å; c = 15.232 Å; β = 126.38° P21/a [78] 
The obtained data of the lattice parameters indicated that α–TCP was presumably 
substituted. This assumption would, however, require confirmation by further experiments, 
in which the content of silica would be reduced until total disappearing of cristobalite phase. 
Afterwards, the lattice parameters of tricalcium phosphates will be measured and the quantity 
of silicon in TCP will be evaluated by EDS analysis. 
Silica substitution has a positive influence mainly on biological properties as was 
mentioned earlier. Nevertheless, the high total amount of cristobalite in structure suggested, 
that if sintered calcium phosphate scaffolds were substituted by silica, only small fraction of 
silica was incorporated into the lattice. The question was how the crystalized silica affected 
the biological and mechanical properties. A great deal of material research was focused on 
bioceramics containing amorphous silica such as Bioglass [42, 55, 67-69], (pseudo) 
wollastonite [142] and Si doped CaP [128, 143, 144]. On the other hand little is known about 
materials composed of crystalline silica in form of quartz or cristobalite. Cristobalite was 
in some studies consider being carcinogenic to human [145-147]. It is undeniable, however 
this feature was connected with inhalation of silica dust of mineral origin which can cause 
silicosis or lung cancer. Fubini [146] conducted several experiments and reported also 
problems related to cytotoxicity of cristobalite dust during cultivation in vitro. Nonetheless, 
the cytotoxicity disappeared upon heating to 1300 °C due to the loss of surface radicals, which 
play a crucial role in silica pathogenicity. The polished surface of quartz behaved unreactive 
even in aqueous medium. These indicates, that sintered cristobalite should not cause any 
adverse reaction. That was confirmed by Zocca [58] who studied ceramic scaffolds containing 
wollastonite with traces of cristobalite in the structure. He did not observe any cytotoxic 
behaviour. The safety of bioceramics containing Si was confirmed by Lai [148] who measured 
excretion of Si from biodegradable glass. He discovered that Si is secreted by urine. 
No increase of Si was found in kidney, liver, lung and lympf nodes. 
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The theoretical density of various composites, necessary to calculate the porosity, was 
calculated based on results of XRD analysis (see Table 17). 
Table 17 Theoretical density of scaffold components 
Phase Theoretical density (g∙cm-3) - XRD 
α-TCP 2.832 
β-TCP 3.485 
Cristobalite 2.253 
Ca4(PO4)2O 3.077 
walstromite 3.1827 
5.4.3 Characterisation of structure and morphology of scaffolds 
Characterisation of scaffold cell size and its distribution 
Fig. 49 and Fig. 50 give an overview of scaffolds with various cell size.  Structure of HA 
scaffold and HA–SiO2 scaffold is very similar. As obvious from Table 18, pores (defined by cell 
size) were slightly larger in case of hydroxyapatite. Pores in HA scaffolds were larger although 
the linear shrinkage was decreasing with increasing silica content (Table 19). This discrepancy 
in result was caused by lower sintering temperature of hydroxyapatite (1200 °C instead 
of 1250 °C).  
Table 18 Pore sizes of HA-SiO2 and HA 
 Cell size (µm) Size of cell windows (µm) 
HA 60ppi 873  ± 55 262 ± 80 
HA 75ppi 532 ± 67 204 ± 78 
HA 90ppi 385 ± 60 116 ± 45 
HA-SiO2 45ppi 1150 ± 198 536 ± 113 
HA-SiO2 60ppi 736 ± 85 287 ± 92 
HA-SiO2 75ppi 498 ± 58 168 ± 45 
HA-SiO2 90ppi 375 ± 37 118 ± 35 
 
 
Fig. 49 HA scaffolds sintered at 1200 °C/3h; porosity of the PU template: (a) 60 ppi, (b) 75 ppi, 
(c) 90 ppi 
a) b) c) 
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Fig. 50 HA-10SiO2 scaffolds sintered at 1250 °C/3h; porosity of the PU template:   
 (a) 45 ppi, (b) 60 ppi, (c) 75 ppi, (d) 90 ppi 
Distribution of scaffold cell sizes after sintering was narrow and unimodal. The pore 
size corresponded to the initial pore size of reticulated PU foam reduced by shrinkage. In terms 
of bone tissue engineering, the ideal starting template was that with porosity of 90 ppi. Both 
cell size and size of windows between cells were adequate for cell colonization and migration. 
Table 19 Linear shrinkage of scaffolds after sintering at 1250 °C/3h 
sample 60 ppi 75 ppi 90 ppi average linear shrinkage 
HA    23.5 ± 3.1 % 
HA-5SiO2 28.1 ± 1.4 % 25.8 ± 3.6 % 26.1 ± 2.9 % 26.6 ± 2.9 % 
HA-10SiO2 25.6 ± 1.7 % 24.7 ± 4.2 % 25.1 ± 1.0 % 25.2 ± 2.3 % 
HA-15SiO2 24.8 ± 1.0 % 23.2 ± 3.3 % 23.4 ± 1.2 % 23.8 ± 2.0 % 
HA-20SiO2 23.3 ± 1.3 % 21.4 ± 2.9 % 22.3 ± 1.7 % 22.4 ± 2.1 % 
  
Table 19 summarizes the linear shrinkage of scaffolds containing different amount of 
silica in structure. It shows that shrinkage is inversely proportional to silica content. The lower 
than expected shrinkage of pure hydroxyapatite was caused by lower sintering temperature 
(1200 °C instead of 1250 °C).  
5.4.4 Characterisation of pore structure of scaffolds 
Strut thickness and porosity was affected by properties of slurry and by processing 
parameters. The lower pore size of template, the lower concentration of powder was 
necessary to use. Fig. 51 illustrates a hollow strut as a consequence of replication of 
reticulated PU foam.  
a) 
 
b) 
 
c) 
 
d) 
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Fig. 51 Strut morphology (a) hollow strut HA5SiO2, 75 ppi; (b) hollow strut HA, 75 ppi 
Porosity was easily tuneable by viscosity of the slurry, by repeating the coating process 
and finally by efficiency of removing the extra slurry by compress air. Samples with huge range 
of porosity (45–98%) were prepared. If the porosity was lower than 50%, the macropores were 
almost closed and remaining pores were too small for cell colonization. Scaffolds with 60–80% 
porosity exhibited interconnected pores with seldom closed walls – it seemed to be ideal 
porosity due to scaffold morphology and strength. If the porosity exceeded 92%, the struts 
were very thin causing the brittle behaviour of sintered scaffold. 
5.4.5 Biological properties - bioactivity 
Bioactivity of prepared scaffolds was tested in Eagle medium instead of in simulated 
body fluid. The ionic composition of MEM (minimum essential medium Eagle) was comparable 
to SBF solution. Fig. 52 presents the overview of surface morphology of prepared scaffolds 
before and after immersion in medium. After 3day cultivation in direct contact assay, the 
surface of scaffolds was covered by newly formed apatite layer. Samples containing silica were 
fully covered whereas layer of apatite precipitated on pure CaP were not continuos. It could 
have been caused by high porosity of the sample. Newly formed apatite layer, nucleated under 
the conditions simulated in vivo indicates a good bioactivity of scaffolds containing 
cristobalite. According to Pietak [128] the bioactivity could have been influenced by presented 
osteoblast cells. He reported that Si-α-TCP showed only little reactivity in SBF environment. 
If SBF contained serum proteins, the precipitation of HCA like phase would have been 
significantly faster. He reported the complete transformation to plate like HA in the presence 
of osteoblast cells. On the other hand Tuck [149] observed biomimetic precipitation at the 
surface of Si-α-TCP scaffold incubated in SBF. It shows that Si promotes biomimetic 
precipitation on Si-α-TCP by higher solubility of the material due to creation of defects in the 
lattice [78, 128, 150]. Pietac studied the influence of surface charge, which is electronegative 
due to substitution of SiO44- for PO43-, this can facilitate surface adhesion, rapid biomimetic 
precipitation and can lead tohigher biological activity [128, 151]. 
Also wollastonite (CaSiO3) based ceramic is consider being bioactive and can be used 
in tissue engineering [59, 152]. Ionic products of pseudowollastonite enhanced osteoblast 
activities [128, 142]. 
a) b) 
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Fig. 52 Surfaces of HA-SiO2 scaffolds before and after 3 day incubation in Eagle Medium. 
Cell colonization 
Cell colonization was tested in direct contact assay with human osteosarcoma cells. 
The percentage of occupied surface corresponded to the amount of seeded cells 
(3500 cells/cm2 after 3 days; see Fig. 53). Results summarized in Fig. 54 indicates that silica 
slightly improved cell adhesion.  
a)    b)  
c)   d)  
Fig. 53 MG 63 cells adhered to the surface of CaP / silica scaffolds: (a) 5% SiO2, (b) 10% SiO2, (c) 15% 
SiO2, (d) 20% SiO2 
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Fig. 54 Percentage of adhered cells on the surface after 3D cultivation  
The cell morphology of MG 63 cells is detailed in Fig. 55. Please note, that the scale bar 
is different for the first figure, HA scaffold. The cell morphology was the typical for MG63 cell 
line in the case of cells adhered to Si-TCP surface – independent on silica concentration. The 
cells were smaller on unsubstituted TC 
a)   b)   c)        
d)   e)  
Fig. 55 Morphology of cells adhered to HA and HA – SiO2 scaffolds. Please note the different scale 
bar in the first image. 
5.4.6 Biocompatibility of calcium phosphate scaffolds with human cells 
Calcium phosphate scaffolds were seeded with human adipose-derived stem cells 
(ADSC) to assess material cytotoxicity. It was performed by determination of cell viability after 
24 hours of cell cultivation with lower concentration (50.000/100 μl). Live cells exhibit green 
fluorescence after acridine orange staining and dead cells exhibit red fluorescence after 
ethidium bromide staining. Cells on all samples exhibited green fluorescence and a few of 
them exhibited red (less than 1%), which is physiological state, indicating that cells were viable 
on materials. All the materials were found biocompatible and nontoxic (see Fig. 56). 
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Fig. 56 Cell viability assessment after 24 hours of cultivation. Cells seeded on scaffolds exhibited 
green fluorescence indicating viable cells (Merged images of red and green fluorescence) for 
both materials: (a) CaP, (b) Si-CaP 
Further biological analyses of materials were investigated to assess the cell adhesion 
and morphology. Nuclei and cytoskeleton were visualised to evaluate their shape and 
distribution, respectively, and observed detailed morphological features. Overall, the cells 
growing in contact with materials adhered and covered its surfaces. Morphology of cells 
seeded on scaffolds was comparable to standard cell appearance on Petri dishes, in high 
concentration cultivation. Cells grew in monolayers and ADSCs formed protrusions in some 
parts of scaffolds indicating active interaction and adhesion to materials. This was mainly 
detected on materials with larger pores (60 and 75 ppi) and that was marked in figures by 
white arrows (Fig. 58). Even more filopodia (protrusion) formation was observed on 
hydroxyapatite-silicium materials, still further analysis of cell behaviour (e.g. proliferation, 
focal adhesion formation) should be assessed for more detailed characterization and 
difference evaluation.  
There was observed also significant phenomenon of overgrowing pores and 
connecting cells in sheets (Fig. 57) on scaffolds with small pores (porosity 90), both materials, 
documenting natural character of cell behaviour and nontoxic character of materials. Taken 
together, no signs of blabbing of cytoplasmic membrane, regularly shaped nuclei, well 
developed network of actin and firm contacts with the supporting materials was observed and 
materials have been found to be biocompatible and suitable for cell culture applications.  
   
a) b) 
a) d) 
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Fig. 57 Morphological features of the cells growing in calcium phosphate: (a) 60 ppi, (b) 75 ppi, 
(c) 90 ppi and Silica/calcium phosphate (d) 60 ppi, (e) 75 ppi, (f) 90 ppi) scaffolds. Red color stains 
actin and the blue visualizes chromatin. White arrows indicate formation of filopodias, green 
arrows cells forming sheets over the pores of scaffolds. 
        
        
b) e) 
f) c) 
a) d) 
e) b) 
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Fig. 58 Detail representation of cellular adhesion and spreading of adipose-derived stem cells on 
hydroxyapatite scaffold (porosity A-60, B-75, C-90) and hydroxyapatite-silicium (D-60, E-75, F-90). 
White arrows indicate formation of filopodias. Scale bar 200 μm. 
5.4.7 Mechanical properties 
Compressive strength of samples with initial pore size 60, 75 and 90 ppi was used for 
evaluation of the influence of silica content on mechanical properties of scaffolds.  
 
Fig. 59 Dependence of compressive strength on total porosity  
Fig. 59 presents dependence of compressive strength on porosity of HA/SiO2 scaffolds. 
Results indicated that strength exponentially increased with increasing density of scaffolds 
according to the Ryshkewitch-Duckworth [153, 154] equation (eq. Xx). 
𝜎 = 𝜎0 ∙ 𝑒
−𝑐𝑝               (8) 
c) f) 
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Where the σ0 is strength at zero porosity, c is constant (4–7 according to porosity) and 
p is porosity.  
It is evident that silica had a positive influence on the strength, no matter if there were 
5 or 20 percent of SiO2 in HA/SiO2 scaffolds. Moreover, it seemed that pore sizes also had 
negligible effect on final strength. One of the requirements imposed on the materials used 
in tissue engineering are properties similar to those of replaced tissues. In the case of 
cancellous bone, the compressive strength values were reported between 1.5 to 38 MPa 
[155], usually 2–20 MPa [19]. Strength-porosity dependence indicated that optimal strength 
for bone tissue replacement was achieved on the samples with lower porosity than 80%. 
Therefore compressive strength of the samples reinforced by silica are similar with those of 
bone and this type of composite material can be potentially used in bone tissue engineering. 
5.4.8 Summary of Chapter 5.4 
Calcium phosphate 3D interconnected scaffolds with different pore sizes were 
fabricated with and without silica addition. Pore dimensions ranging between 375 and 
1150 µm were depended on the pore size of four templates which were replicated. The 
average window size between two interconnected pores was from 118 to 536 µm, ideal for 
cell penetration. Addition of silica (5 – 20 wt. %) strongly influenced the phase transformation 
of hydroxyapatite to β–TCP and α–TCP, respectively. The ratio of α–TCP to β–TCP increased 
fivefold with increasing silica content. Lattice parameters indicated that TCP was substituted 
by Si. However, almost all amorphous silica was transformed to the cristobalite crystalline 
phase. Addition of cristobalite did not negatively influence the biological properties as was 
confirmed by two methods – by direct contact assay with osteosarcoma cell line MG63. After 
three days of cultivation, the surfaces were totally covered by newly formed apatite layer 
which indicates excellent bioactive behaviour. Influence of 10% addition of silica on cell 
viability of adipose derived stem cells was also studied. The cell viability increased with 
addition of silica; it seemed that silica supported cell adhesion. This trend was followed for 
the three pore sizes, with the maximum effect noted for the scaffolds using 90 ppi polymer 
pore size. The main enhancement was, nevertheless, observed on mechanical properties. The 
compressive strength of calcium phosphate scaffold bonded by polyvinylalcohol was only 
0.3 MPa at 80% porosity. The strength of scaffolds composed of silica reinforced calcium 
phosphates on the contrary exceeded 20 MPa at 50% porosity. 
5.5 Calcium phosphate scaffolds produced from CaP / PU 
composite foam 
5.5.1 Thermal decomposition of CaP / PU scaffold 
As was mentioned in Chapter 4.3.2, ceramic foams were obtained by burning out 
the polymer from the CaP / PU composites. To determine the temperature at which 
the thermal decomposition of polyurethanes is finished, the thermal analysis was carried out. 
In general, the thermal degradation of polyurethanes in air atmosphere is a complex 
process involving oxidation of the initial polyol and isocyanate components, which is followed 
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by the thermal decomposition that leads namely to the formation of amines, water and 
carbon dioxide [156, 157].  
TA curves (performed on the sample HA100_2_105) are shown in Fig. 60. The total 
weight loss as a consequence of decomposition was 50 wt. %, which corresponded to the 
weight content of polyurethane in the input composition. The first endothermic drop on DTA 
curve below 100 °C was due to water evaporation. Increasing the temperature above 200 °C, 
the polyurethane started to decompose by a typical two stage process as is evident from the 
DTG and DTA curves. The weight loss, around 350 °C was caused by the degradation 
(oxidation) of hydroxyl and amino groups whereas the second stage, around 600 °C was mainly 
associated with the oxidation of the residual carbon. 
 Even though the decomposition of organic compounds was completely finished 
around 750 °C, the CaP / PU composites were heat treated at 800 °C/2 h to ensure 
the sufficient handling strength of presintered ceramic bodies. 
 
 
Fig. 60 TA analysis of polyurethane composite (HA100_2_105) 
5.5.2 Phase composition 
Hydroxyapatite was chosen as a starting powder to fill the polyurethane. Two powders 
were used – untreated commercial one (Fluka) and the same one calcined at 800 °C/1 h 
(↑3 °C/min). The calcination of the powder had several benefits, such as elimination 
of organic impurities or coarsening the grains which facilitates processing of ceramics [158]. 
According to the results of thermal analysis of hydroxypatite, which are shown in Fig. 
61, approximately 5 wt. % of impurities were fired below the calcination temperature. After 
the evaporation of physically adsorbed water, the organic residues (mainly acetates) were 
oxidized between 200 and 500 °C. Above 600 °C, hydroxyapatite was gradually 
dehydroxylated, having released of OH− ions (H2O) and progressively transformed through 
oxyhydroxyapatite (Ca10(PO4)6(OH)2−2xOx□x) to oxyapatite (Ca10(PO4)6O) [159]. With further 
increasing of temperature (above 1100 °C), the oxyapatite has been decomposed into other 
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calcium phosphates such as α, β-TCP (Ca3(PO4)2) and tetracalcium phosphates (Ca4(PO4)2O), 
according to the following reactions [135, 136, 160]: 
𝐶𝑎10(𝑃𝑂4)6(𝑂𝐻)2
−𝐻2𝑂
→   𝐶𝑎10(𝑃𝑂4)6𝑂
 
→ 2𝐶𝑎3(𝑃𝑂4)2 + 𝐶𝑎4(𝑃𝑂4)2𝑂        (9) 
or 
𝐶𝑎10(𝑃𝑂4)6(𝑂𝐻)2
−𝐻2𝑂
→   𝐶𝑎10(𝑃𝑂4)6𝑂
 
→ 3𝐶𝑎3(𝑃𝑂4)2 + 𝐶𝑎𝑂       (10) 
 
Fig. 61 TA analysis of commercial hydroxyapatite (Fluka) 
 
The thermal analysis cannot distinguish the specific phases of decomposition process 
of hydroxyapatite and therefore the phase composition of two started powders and ceramic 
scaffolds sintered at three different temperatures were determined by means of XRD analysis. 
All measured data are summarized in Fig. 62. XRD peaks of diffraction patterns of uncalcined 
starting powder (see Fig. 62 (a)) almost corresponded to the standard in powder diffraction 
file of hydroxyapatite 22059-ICSD, the rest (less than 10%) was identified as monetite 
(CaP3OH). After the calcination at 800 °C (see Fig. 62 (b)), the quantity of hydroxyapatite 
in composition decreased to 80 wt. %. Despite the expectation, no oxyapatite was identified, 
possibly due to rehydroxylation. However, already at this temperature, hydroxyapatite was 
partially decomposed into beta tricalcium phosphate β-TCP (20 wt. %). Scaffold sintered 
at 1050 °C contained about 55 wt. % of hydroxyapatite and 45 wt. % of β–TCP. With 
an increasing sintering temperature, the quantity of hydroxyapatite decreased to 4 wt. %, 
the rest was decomposed into calcium phosphates (48 wt. % α–TCP and 48 wt. % β–TCP). This 
is an interesting result because according to some other authors [136], hydroxyapatite should 
remain stable until at least 1200 °C. Regard to tissue engineering, the decomposition of HA 
is not undesirable process because the degradable calcium phosphates follow the current 
trend in medicine supporting regeneration instead of permanently replacements [161]. 
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Furthermore, patterns show that the mass fraction of more soluble α–TCP increased with the 
temperature (from 48 wt. % at 1200 °C to 75% at 1350 °C). This indicates that structures 
obtained at high sintering temperature would be at the same time more soluble in body 
environment, i.e. would degrade faster than their less dense counterparts [27] and moreover 
it seems that the degradation rate could be controlled by the sintering temperature. 
At samples sintered at 1350 °C, 1.5 wt% of tetracalcium phosphate was found in the xrd 
pattern, it suggest that degradation occurs according to the equation Eq. 10. 
 
Fig. 62 XRD patterns of (a) commercial HA powder; (b) HA powder calcined at 800 °C; (c) HA sintered 
at 1050 °C/2 h; (d) at 1200 °C/2 h and (e) at 1350°C/2 h. 
5.5.3 Foam characterisation -  influence of chemical composition 
Influence of the amount of added water, isocyanate index, ratio between calcium 
phosphate and polyurethane referred as CaP/PU ratio and sintering temperature on the final 
morphology was evaluated. Calculated values of total porosity are summarized in Table 20. 
and in Fig. 63. Individual effects will be discussed in detail in the following chapters. 
Table 20 Scaffold composition and total porosity at different temperatures 
sample 
 Total 
porosity (%) 
calculated  
Total 
porosity (%) 
1050 °C/2 h  
Total 
porosity (%) 
1200 °C/2 h 
Total 
porosity (%) 
1350 °C/2 h 
HA100_0_105 91.0 ± 1.8 87.0 ± 0.9 75.3 78.1 
HA100_1_105 92.1 ± 0.7 86.9 83.6 83.6 
HA100_2_105 92.3 ± 1.3 90.5 79.0 81.0 
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HA100_3_105 91.4 ± 0.7 85.2 79.5 82.2 
HA100_4_105 92.2 ± 1.0 87.5 81.6 84.8 
HA100_5_105 92.0 ± 0.5 87.4 81.3 80.4 
HAu100_0_105 91.3 ± 0.6 83.0 ± 1.9 79.3 81.3 
HAu100_2_105 93.9 ± 0.9 87.9 87.8 85.8 
HAu100_4_105 90.7 ± 1.0 77.9 75.1 78.5 
HA62_0_105 96.2 ± 0.1 90.9 88.4 88.2 
HA56_1_105 97.0 ± 0.1 91.0 89.4 89.0 
HA51_2_105 97.5 ± 0.6 91.7 91.3 90.7 
HA47_3_105 97.3 ± 0.3 93.6 92.6 × 
HA43_4_105 97.9 ± 0.2 × × × 
HA40_5_105 98.0 ± 0.2 × × × 
HA100_2_75 94.8 ± 0.4 90.7 ± 0.1  87.6 88.0 
HA100_2_85 91.3 ± 0.5 85.3 ±1.8 79.0 76.9 
HA100_2_95 93.0 ± 0.6 89.7 ±.6 81.8 82.7 
HA100_2_115 93.0 ± 1.0 89.4 81.1 81.5 
HA100_2_125 92.9 ± 0.8 86.7 84.5 84.1 
HA40_2_105 97.8 ± 0.1 91.4 89.9 90.3 
HA60_2_105 95.5 ± 0.1 91.7 ± 0.3 88.7 90.2 
HA80_2_105 93.6 ± 0.4 86.8 ± 0.6 84.4 83.6 
HA120_2_105 92.4 77.3 76.5 75.9 
HA40_4_105 97.2 ± 0.2 × × × 
HA60_4_105 96.4 ± 0.4 ×  × 90.6 
HA80_4_105 96.9 ± 0.7 90.0 87.5 88.7 
HAu61_0_107 97.4 ± 0.5 91.2 89.7 ± 0.4 89.3 
TCP74_0.5_95 96.8 ± 0.1 91.1 89.5 ± 0.3 76.1± 4.4 
 
 
Fig. 63 Influence of water and powder content on total porosity after burning the polyurethane. 
Width of columns is growing in dependence on INCO from 75 to 105. 
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Influence of the powder composition 
Effect of two hydroxyapatite powders and one β-TCP powder on processability and 
properties of CaP / PU composites were studied. The specific surface area of β-TCP powder 
was 12.4 m2/g. The processability of the foams was quite good, resulting in a regular porous 
structure with narrow distribution of pore sizes (see detail in Fig. 64). Total porosity of 
β-TCP / PU before sintering was slightly higher than HA / PU. If the content of the powder was 
lower than the content of the polyurethane and the INCO was below 100, the prepared foams 
were soft and could have been easily formed into complex shapes (Fig. 64) without damaging 
the macrostructure. Despite these promising results, β-TCP had been abandoned, because it 
behaved thermally unstable and even at 1200 °C it adversely reacted with alumina substrate 
during sintering in air. After the sintering at 1350 °C/2h, the final volume approximately eight 
times shrunk and macroporous structure was totally lost. 
 
 
 
   
Fig. 64 Processing of β-TCP scaffold (TCP74_0.5_95). From left to right: shaped β-TCP/PU composite, 
heat treated at 800 °C and sintered at 1350°C/2h; (b) scaffold sintered at 1200 °C/2 h.  
The second studied system was based on hydroxyapatite powder and polyurethane. 
As was mentioned and explained in chapter 5.5.2, some of the powder was calcined, resulting 
in decrease of the specific surface area from 33.8 m2/g to 8.1 m2/g. Powder calcination 
influenced the behaviour of powder/polyol/MDI mixture and final properties of prepared 
foams. Since uncalcined powder exhibited high specific surface area, it was difficult to mix all 
powder with the polyol. It was necessary to mix the part of the powder (especially in the 
sample with 4 pphp H2O) with diisocynate before the final mixing of all components. The very 
high viscosity of resulted mixture negatively influenced the microstructure of prepared foams. 
It seemed that components containing uncalcined powder had worse foaming ability, which 
was confirmed by lower apparent porosity. Microstructure of the sintered foam is shown 
in Fig. 65c. Next drawback of using too viscous mixtures was incorporation of irregular pores 
68 
 
into the structure as a result of not homogenously filled mould (it is demonstrated in Fig. 65a). 
The prepared foams were moreover more rigid in comparison with their counterparts 
prepared from calcined powder. The rigidity complicated the ability to cut and shape them 
after the hardening. 
 
Fig. 65 Scaffold prepared from uncalcined powder: (a) CaP/PU composite after hardening (HAu 
100_4_105), (b) samples containing 0, 2, 4 pphp sintered at 1050 °C,  (c) SEM micrograph of HAu 
100_2_105_1200. 
Effect of added water 
Two sets of samples with an increasing amount of added water were evaluated (see 
Fig. 66 and Fig. 67). Pictures indicated that water addition (from 0 to 5 pphp) had a significant 
impact on the structure of the composites, mainly on pore size. During the processing water 
as blowing agent reacted with the NCO  ̶ functional groups of diisocyanate and formed 
unstable carbamic acid which immediately decomposed into an amine and carbon dioxide 
which caused generation of pores in the structure [162]. Reaction ran according to the 
following scheme: 
 (11) 
 
 
Fig. 66 CaP/PU foams having ha/pu ratio = 1 and INCO = 105 (water content increasing from 0 wt.% 
(left) to 5 wt% /(right) of polyol) 
a) 
b) 
c) 
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Fig. 67 CaP/PU foams having ha/polyol ratio = 1 and INCO = 105 (water content increasing from 0 
wt.% (left) to 5 wt% /(right) of polyol) 
Theoretically, 1 mol of H2O would create 22.4 dm3 of CO2. If all the created bubbles 
were stable and remained in the foam, the total volume (and apparent porosity) of the foam 
would rise with the increasing amount of water. However, this was not experimentally 
confirmed; the results summarized in Fig. 68 indicated that apparent porosity was more or 
less independent on the water content. A slight increase of porosity of samples containing 
equal amount of powder as polyol was probably caused by different powder to polyurethane 
ratio, not by water. 
 
Fig. 68 Influence of water and powder content on porosity calculated from weight, dimensions and 
theoretical density of hydroxyapatite 
Although the total volume of pores was almost the same, the additive water influenced 
individual pore sizes and their distribution (see Fig. 69 and Fig. 70). Pore sizes were determined 
by image analysis of polished cross sections cut 3 mm below the top of PU / HA foam, sintered 
at 1050 °C/2h. All pores having diameter larger than 5 μm were measured on the area 25 mm2 
per one sample. Results are summarized in Table 21. Since the pores were measured in 2D, 
the real (3D) diameters are larger [109]. Assuming that the pores are ideal spheres and 
according to the probability of cutting a sphere in different distances far from the largest 
diameter, the average pore diameters can be simply multiplied by a constant 1.57. This 
approach is not statistically completely right, detailed explanation of sphere unfolding and 
particle size distribution in 3D from 2D data can be found elsewhere [163-165]. 
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Fig. 69 Overview of cross sections of ceramic scaffolds sintered at 1050 °C: top row: 
mHA =  mpolyurethane, from 0 (left) to 5 pphp (right); bottom row: mHA = mpolyol, from 0 (left) to 3 pphp 
(right) 
As is obvious from Fig. 70, the pore size distribution (in 2D) was skewed right, 
the number of small pores was several times higher than the large ones. For differentiation 
of the influence of large and small pores which highly probably were not all slices of larger 
ones, an average size of 10% of the highest measured values was also calculated (see Table 
21). It appeared that all of these large pores were interconnected and they formed the greater 
part of the surface area and they could be suitable for cell colonization. 
     
     
Fig. 70 Histograms of measured pore sizes: (a) mHA = mpolyurethane; (b) mHA = mpolyol 
 
a) b) 
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Table 21 Pore sizes estimated from cross section of scaffolds sintered at 1050 °C/2 h 
 
HA/PU 1 1 1 1 1 1 0.62 0.56 0.51 0.47 
H2O (wt. % of polyol) 0 1 2 3 4 5 0 1 2 3 
Porosity (image analysis) 78.8 61.0 64.8 59.7 60.6 67.2 81.7 84.7 85.9 88.4 
Standard deviation (%) 0.5 2.3 2.6 1.2 2.9 2.9 0.6 0.7 0.3 1.3 
Average pore size (μm) 94 65 79 65 86 93 86 125 109 124 
Standard deviation (μm) 59 57 71 89 107 134 54 59 59 82 
Avg pore size ∙ 1.27 (μm)  120 83 100 83 110 118 110 159 139 158 
10% largest pores (μm) 209 184 223 271 326 423 200 245 228 301 
St. deviation 10% (μm) 59 61 79 144 157 169 57 77 47 99 
Avg pores 10% ∙ 1.27 (μm) 266 234 284 345 415 539 255 312 290 383 
 
Effect of isocyanate index 
According to the literature search [166-168], the isocyanate index INCO of rigid 
polyurethane foams should varied between 105 and 125. To ensure the complete reaction of 
all the OH groups, the isocyanate index INCO was preferentially set to 105. If INCO was below 100 
some of OH groups did not react and excess of polyol made a final foam soft and easily cut. 
And vice versa, higher INCO led to more rigid foams because the excess of diisocyanate caused 
the cross-linking of the polymer chains [168]. 
Fig. 71 demonstrated that apparent porosity was not significantly influenced by an 
isocyanate index except of the lowest value of INCO = 75. Volume of this blown polyurethane 
foam sample was almost doubled against the others. However, what was strongly influenced 
by INCO was the ease of manufacturing and shaping after the curing. Composites having high 
INCO exhibited higher viscosity of mixture during processing due to low polyol / powder ratio. 
In Fig. 72, there is a demonstration how easily foam can be cut into required shapes. The idea 
was to prepare 1.2cm high cylinders. It was achieved only with the lowest indexes (INCO = 75 
and 85); whereas the rigid composites behave very brittle and shaping after the curing was 
almost impossible. 
 
Fig. 71 The dependence of isocyanate index on apparent porosity 
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The easiness of shaping after the foam hardening (or isocyanate index) had a crucial 
influence on structure and behaviour of foams after the sintering. Examples of foams sintered 
at 1050 °C/ 2 h are in Fig. 73. Foams with a regular shape and low INCO were strong even while 
maintaining high porosity (above 90%). The foam with the highest INCO = 125 sintered at 
1050 °C did not exhibited even the handling strength. This might have been due to the defects 
created during shaping or because of inhomogeneous internal structure caused by difficult 
mixing of reactants. As is evident from micrographs in Fig. 74, microstructure was influenced 
by isocyanate index; lower index led to smooth defect‒free surface.  
 
 
Fig. 72 An overview of prepared composites with different isocyanate index  
 
Fig. 73 Ceramic foams with different isocyanate index after heat treatment at 1050 °C/2h 
 
Fig. 74 Microstructrures of scaffolds with different isocyanate indexes (INCO = 75, 105, 125) 
HA/PU = 100 %, 2 % H2O, sintered at 1350 °C/2 h 
Effect of CaP / polyurethane ratio 
The capability of the composite to blow and achieve a specific volume was mainly 
influenced by the properties of the polyurethane binder. The higher powder / polymer ratio, 
the worse processability of the composite and the lower final volume were observed. 
Nonetheless, the significant difference in structure and porosity was apparent after the 
burning out of organic components. Fig. 63 and Fig. 75 indicated that the CaP / PU ratio had 
the highest influence on apparent porosity and because strength is proportional to it, HA / PU 
ratio was probably the most important parameters of all tested ones.  
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Fig. 75 Effect of HA / PU ratio on apparent porosity (INCO = 105; 2% H2O) 
 
 
Fig. 76 Structure of prepared composites with different HA  / PU ratio (2 % H2O, INCO = 105)  
 
Fig. 77 Microstructure of ceramic scaffolds at different HA/PU ratio: 0.51 on the left and 1 on the 
right (2 % H2O, INCO = 105, 1200 °C/2h) 
 
Ceramic foams having constant HA/polyol ratio exhibited very high porosity resulted 
in poor mechanical properties (even insufficient handling strength). All samples which had 
ha/pu ratio below 0.6 and simultaneously contained 4 or 5 pphp of water were destroyed 
in the furnace during the burnout of the polymer (see Fig. 78). This could have been due to 
the fact that the proportion of powder (calculated porosity exceeding 97.5 %) was so small 
that the individual ceramic particles have not been in contact to each other and adjacent 
polymer layer was too thick to enable compacting of green ceramic body by diffusion. 
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Fig. 78 Overview of scaffolds containing 4% H2O: (a) ha/pu = 0.4, (b) ha/pu = 0.6, (c) ha/pu = 0.8 
It seems that the ideal defect–free scaffolds with interconnected pores suitable for 
application in bone tissue engineering should have ha / pu ratio lower than 1 (see Fig. 77). 
Effect of sintering temperature  
As already indicated in Table 20, the apparent porosity and pore sizes decreased with 
an increasing sintering temperature. The linear shrinkage of ceramics having HA / PU ratio = 1 
was 15 ± 1 % at 1050 °C,  22.7 ± 1.3 % at 1200 °C and 24.2 ± 1.3 % at 1350 °C. For ceramics 
having HA / polyol ratio = 1, the linear shrinkage was depended on HA / PU ratio. Generally, 
the shrinkage increased with the increasing porosity. For scaffolds with HA / PU < 1, it reached 
almost 20 % at 1050 °C and about 30 % at 1200 and 1350 °C. The differences in macrostructure 
(see Fig. 79) are negligible due to wide distribution of pore sizes.  
 
Fig. 79 Micrographs of HA100_2_105 scaffold sintered at different temperatures: (a) HA/PU 
composite before calcination; (b) scaffold sintered at 1050 °C; (c) 1200 °C; (d) 1350 °C (the 
magnification is the same for all 4 photos). 
Besides changes of phase composition which were described thoroughly in chapters 
5.5.1 and 5.5.2, the microstructure was dramatically changed by the sintering temperature. 
PU/HA composite had very smooth surface as is evident from left quarter of Fig. 80 (PU+HA), 
the rough middle part of the same photo is a fracture area where the relief was caused by 
pulling out of ceramic particles. With an increasing temperature, the grains significantly 
coarsed and microporosity was reduced. 
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Fig. 80 Microstructures of HA100_2_105 scaffold sintered at different temperatures: (a) HA/PU 
composite before calcination; (b) scaffold sintered at 1050 °C; (c) 1200 °C; (d) 1350 °C (the 
magnification is the same for all 4 photos). 
5.5.4 Mechanical properties 
The compressive strength of tested samples varied between 0.2 and 0.3 MPa. Hence, 
the strength was similar to strength of hydroxyapatite foams prepared by polymer replica 
technique. This value was not so bad for samples reaching almost 90% porosity. Scaffolds with 
the same porosity did not exhibit neither handling strength in the case of replica method. The 
preparation process of the tested specimens however was not ideal. Cylinders were shaped 
after the hardening of the composite. This could lead to generation of defects in the 
macrostructure which could consequently negatively influenced the measured values. The 
compressive strength could be enhanced by direct casting of mixture to the form of optimal 
geometry, such as cylinders with height to diameter ratio equal to 1.5. 
Concerning fracture mechanism, the shapes of loading curves (in Fig. 81) show almost 
the same stress during loading – it indicates that struts were destroyed one by one. Two 
samples, represented by blue and red loading curves, were loaded until they were completely 
crushed to powder. This mechanism is called densification. 
 
Fig. 81 Compressive stress dependence on time of loading 
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5.5.5 Summary of Chapter 5.5 
Porous calcium phosphate scaffolds were successfully prepared by polymerization in 
situ using diisocyanate, polyol and water. Generation of carbon dioxide led to formation of 
large interconnected pores. The total porosity of scaffolds decreased from 99 to 76% as the 
powder content increased, leading to denser and thicker pore walls between interconnected 
pores. On the other hand, the total porosity was almost independent on percentage of added 
water (up to 5 pphp, parts per hundred parts of polyol). However, water influenced pore size. 
Average pore size increased from 65 μm (1 pphp) to 93 μm (5 pphp). Sizes of 10 % of larges 
pores suitable for cell colonization were enlarged from 234 μm to 539 μm just due to water 
addition. Because the scaffolds are formed by in situ polymerization, the shape of scaffold can 
be easily controlled by the shape of mould. The porosity and pore size is tuneable just by 
powder / polyol / diisocanate / water ratio.  
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6 CONCLUSIONS 
 
Open three-dimensional ceramic scaffolds with interconnected macropores were 
prepared by polymer replica technique or by polymerization in situ. Ceramic scaffolds were 
obtained in both cases after burning out the polyurethane and other binders from the 
structure. Regarding the replica technique, the morphology of scaffolds mimicked the 
morphology of commercial reticulated polyurethane templates. Cell size and its distribution 
was controlled by used template. The total porosity was tailored by viscosity of suspension 
and by number of applied layers.  
The first studied system was based on alumina. Open-cell alumina foams were prepared 
by replica method from nanosized boehmite powder and fused microsized alumina. Highly 
porous reticulated alumina foams exhibited low compressive strength (< 0.25 MPa) because 
of high total porosity (> 95%), low microstructure density (~ 50%) and because of voids inside 
the struts generated during polyurethane burnout. The strength was at least doubled due to 
scaffold infiltration by nanosized boehmite, although the struts remained partially unfilled. 
The successful approach was strut filling by suspension composed of finer alumina particles 
having allowed about fourfold increase of strength. Mechanical properties were improved, 
however, material was biologically inert. To shift biological properties to bioactive behaviour, 
the foams were coated by hydroxyapatite suspension. All components, namely porous core, 
reinforcing phase (/layer) and bioactive coating, seemed to firmly adhere to each other. For 
application in bone tissue engineering it would be necessary to reduce pore sizes to maximally 
500 μm and simultaneously improved the compressive strength, e.g. by decreasing total 
porosity below 85 %.  
The second research area dealt with alumina toughened zirconia scaffolds. Macroporous 
scaffolds with interconnected pores of size ranging from 350 to 1200 µm were prepared by 
similar way as previously described foams. The difference was that yttria stabilized zirconia 
was used instead of fused alumina. Based on results of the mechanical testing, 5 wt. % content 
of alumina was chosen as optimum for further experiments. Scaffolds of various total porosity 
(57–98%) were fabricated by multiple coating process (up to 6 cycles). The bioactive behaviour 
of the composite was achieved by coating of calcium phosphates. Besides bioactivity and 
cytotoxicity tests, the cell colonization in 3D scaffold was evaluated. It was shown that MG-63 
cells grew through the scaffold with 1000 µm large pores after three-day cultivation, the same 
amount of cells was found both adhered to the outer and inner struts of scaffold.  
The main disadvantage of these two types of scaffolds was the bioinert core. The current 
trend of tissue engineering are resorbable materials that help bones to regenerate instead 
of formerly used permanent replacements, so the attention was focused on calcium 
phosphate scaffolds. 
Calcium phosphate 3D interconnected scaffolds with different pore sizes were fabricated 
with and without silica addition. Pore dimensions ranging between 375 and 1150 µm were 
depended on the pore size of four templates which were replicated. The average window size 
between two interconnected pores was from 118 to 536 µm, ideal for cell penetration. 
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Addition of silica (5– 20 wt. %) strongly influenced the phase transformation of hydroxyapatite 
to β–TCP and α–TCP, respectively. The ratio of α–TCP to β–TCP increased fivefold with 
increasing silica content. Lattice parameters indicated that TCP was substituted by silicate 
ions. However, almost all amorphous silica was transformed to the cristobalite crystalline 
phase. Addition of cristobalite did not negatively influenced the biological properties. Testing 
in direct contact assay with MG63 cells showed that percentage of covered surface slightly 
increased with increasing silica content. After three days of cultivation, the surfaces were 
totally covered by newly formed apatite layer which indicates excellent bioactive behaviour. 
The cell viability increased with addition of silica; it seemed that silica supported cell adhesion. 
This trend was followed for the three pore sizes, with the maximum effect noted for the 
scaffolds using 90 ppi polymer pore size. The main enhancement was, nevertheless, observed 
on mechanical properties. The compressive strength of calcium phosphate scaffold bonded by 
polyvinylalcohol was 0.3 MPa at 80% porosity. The strength of silica reinforced calcium 
phosphates scaffolds exceeded 20 MPa. 
From previous paragraph is obvious that preparation of calcium phosphate scaffolds by 
replica technique was from mechanical point of view less successful. For this reason a novel 
processing technique was developed to overcome the low strength caused by internal defects 
and hollow struts. Porous calcium phosphate scaffolds were successfully prepared by 
polymerization in situ using diisocyanate, polyol and water. Generation of carbon dioxide led 
to formation of large interconnected pores. Pores smaller than 5 µm were created by 
polymeric binder burnout during sintering. This small interconnected pores can be convenient 
for supply of nutrients and oxygen. The total porosity of scaffolds decreased from 99 to 76% 
as the powder content increased, leading to denser and thicker pore walls between 
interconnected pores. On the other hand, the total porosity was almost independent on 
amount of added water (up to 5 pphp, parts per hundred parts of polyol). However, water 
influenced pore size. Average pore size increased from 65 μm (1 pphp) to 93 μm (5 pphp). 
Sizes of 10 % of larges pores suitable for cell colonization were enlarged from 234 μm to 
539 μm just due to water addition. Because the scaffolds are formed by in situ polymerization, 
the shape of scaffold can be easily controlled by the shape of mould. The porosity and pore 
size is tuneable just by powder / polyol / diisocanate / water ratio. On the basis of 
morphological observations, the calcium phosphate scaffolds could be promising adepts for 
synthetic bone grafts.  
The aim of this thesis, to fabricate three-dimensional scaffolds that can be potentially 
used in bone tissue engineering, was achieved. Neither of the studied materials was cytotoxic 
and moreover all prepared composites behave bioactive in simulated body fluid. The most 
promising adept for application in bone tissue engineering seems to be composite material 
containing calcium phosphates reinforced by silica. 
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LIST OF ABBREVIATIONS 
 
2D  two dimensional 
3D   three dimensional 
3D-P   three dimensional powerbed based printing 
AFM  atomic force microscopy 
ATZ  alumina toughened zirconia 
A/W  apatite / wollastonite 
BCP  biphasic calcium phosphates 
CAD  computer aided design 
CaP  calcium phosphate 
DCP  anhydrous dicalcium phosphate 
DCPD  dicalcium phosphate dehydrate 
HA  hydroxyapatite 
HCA  hydroxy carbonate apatite 
MDI  methylene diphenyl diisocyanate 
MSC  mesenchymal stem cells 
MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H-tetrazolium) 
MTT  methylthiazol tetrazolium 
OCP  octocalcium phosphate 
PA  polyamide 
PCL  polycaprolactone 
PEG  polyethylene glycol 
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